10-K/A 1 b44234a1e10vkza.txt LUMENON INNOVATIVE LIGHTWAVE TECHNOLGY, INC. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ------------------ FORM 10-K/A AMENDMENT NO. 1 TO FORM 10-K FOR ANNUAL AND TRANSITION REPORTS PURSUANT TO SECTIONS 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Mark One) [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2002 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________________ to ___________________ Commission File number 000-27977 LUMENON INNOVATIVE LIGHTWAVE TECHNOLOGY, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 98-0213257 (State or Other Jurisdiction of I.R.S. Employer Incorporation or Organization) Identification No.) 8851 Trans-Canada Highway, St-Laurent, Quebec, Canada H4S 1Z6 (Address of Principal Executive Offices) (Zip Code)

Registrant's telephone number, including area code: (514) 331-3738 Securities registered pursuant to Section 12(b) of the Act: None Securities registered pursuant to Section 12(g) of the Act: Common Stock, $0.001 Par Value (Title of Class) Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ] Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of the registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. [ ] The aggregate market value of the voting stock held by nonaffiliates of the registrant, as of September 20, 2002, based on the last sale price of the registrant's common stock at the close of business on September 20, 2002, was US$5,396,812. The registrant has no non-voting stock. There were 41,145,197 shares of common stock, US$0.001 par value, of the registrant outstanding as of September 20, 2002. EXPLANATORY NOTE This Amendment No. 1 to the Registrant's Annual Report on Form 10-K, originally filed on September 30, 2002, is being filed to amend and restate Part III of the Annual Report on Form 10-K in its entirety. Part III of this Form 10-K/A will not incorporate by reference to the Registrant's definitive Proxy Statement for its 2002 Annual Meeting of Stockholders as the Proxy Statement will be filed with the Securities and Exchange Commission later than 120 days after June 30, 2002. This Amendment No. 1 to Annual Report of Form 10-K does not reflect events occurring after the September 30, 2002 filing of our Annual Report on Form 10-K for the fiscal year ended June 30, 2002 or modify or update the disclosures set forth in that Annual Report on Form 10-K in any way. There is no change to the Registrant's consolidated financial statements, the notes to the consolidated financial statements, or the report of the independent auditors. DOCUMENTS INCORPORATED BY REFERENCE None. FORWARD-LOOKING STATEMENTS This Annual Report on Form 10-K/A includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 that are subject to a number of risks and uncertainties. All statements, other than statements of historical facts, included in this Annual Report on Form 10-K/A regarding our strategy, future operations, financial position, estimated revenues, projected costs, prospects, plans and objectives of management are forward-looking statements. When used in this Annual Report on Form 10-K/A, the words "will", "believe", "anticipate", "intend", "estimate", "expect", "project" and similar expressions are intended to identify forward-looking statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures or strategic alliances. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors, including risks described in "Management's Discussion and Analysis of Financial Condition and Results of Operations" and elsewhere in this Annual Report on Form 10-K/A. We do not assume any obligations to update any of the forward-looking statements we make. WEB SITE ADDRESS Our web site address is www.lumenon.com. References in this Annual Report on Form 10-K/A to www.lumenon.com or any variations of the foregoing or any other uniform resource locator or URL are inactive textual references only. The information on our web site or at any other URL is not incorporated by reference into this Annual Report on Form 10-K/A and should not be considered to be a part of this document. TRADEMARKS Lumenon(TM) and PHASIC(TM) are trademarks of Lumenon Innovative Lightwave Technology, Inc. Other product, company or organization names cited in this Annual Report on Form 10-K/A may be service marks, trademarks or trade names of their respective companies or organizations. TABLE OF CONTENTS PART I............................................................................... 1 Item 1. Business............................................................. 1 Item 2. Properties........................................................... 7 Item 3. Legal Proceedings.................................................... 8 Item 4. Submission of Matters to a Vote of Security Holders.................. 8 PART II.............................................................................. 9 Item 5. Market for Registrant's Common Equity and Related Stockholder Matters.............................................................. 9 Item 6. Selected Financial Data.............................................. 10 Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations................................................ 12 Item 7A. Quantitative and Qualitative Disclosures about Market Risk........... 28 Item 8. Financial Statements................................................. 29 Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure................................................. 29 PART III............................................................................. 30 Item 10. Directors and Executive Officers of the Registrant................... 30 Item 11. Executive Compensation............................................... 31 Item 12. Security Ownership of Certain Beneficial Owners and Management....... 38 Item 13. Certain Relationships and Related Transactions....................... 42 Item 14. Controls and Procedures.............................................. 42 PART IV.............................................................................. 43 Item 15. Exhibits, Financial Statement Schedules, and Reports on Form 8-K..... 43

i PART I ITEM 1. BUSINESS. OVERVIEW Lumenon is a development stage photonics technology company engaged in the design, development and building of optical components and devices in the form of compact hybrid glass circuits on silicon chips for equipment providers in the telecommunications, data communications and cable television markets. Our core competencies include optical design, materials development and processing and packaging for enhanced device integration and performance. Our original photonic hybrid active silica integrated circuit process technology has been trademarked under the name PHASIC(TM) to encapsulate the concept of an end-to-end technology platform ranging from design and materials science through manufacturing. Our primary goal with respect to PHASIC(TM) is to complete the development of PHASIC(TM) so that products can be manufactured and sold on a commercial basis. LUMENON HISTORY We were incorporated in Delaware in February 1996 under the name WWV Development, Inc. In July 1998, we acquired all of the issued and outstanding shares of Lumenon Innovative Lightwave Technology, Inc., a Canadian corporation, now called LILT, which was founded in March 1998 by Dr. Iraj Najafi and Dr. Mark P. Andrews. Upon consummation of the acquisition, we changed our name from WWV Development, Inc. to Lumenon Innovative Lightwave Technology, Inc. Our common stock is currently listed on The Nasdaq SmallCap Market under the symbol "LUMM". Since inception, Lumenon has been engaged in the research and development of its technology platform and the construction of its optical components manufacturing facility. Investments and costs have been financed mainly through various debt and equity financings. As of June 30, 2002, since inception we have raised CDN$71.6 million through convertible notes, debt and equity financings. INFRASTRUCTURE Lumenon is located in a "photonics corridor" which consists of clusters of photonics companies in the eastern seaboard of the United States and Canada, including Montreal and Ottawa, where Nortel Networks Corp. and JDS Uniphase Corp. are principally headquartered. We are adjacent to five universities in Montreal, where we make use of selected laboratories provided by the universities to supplement our research and engineering development activities. Over the past eighteen months, we have also invested significant effort and resources to establish and maintain our photonics facility to conduct our research, development and production. Being based in Quebec, Canada, we are able to take advantage of Canadian provincial and federal research and development tax incentive programs including, on the provincial level, 20% refundable tax credits on salaries of employees involved in research and development. 1 At the heart of our 53,000 square-foot building in St. Laurent (Montreal, Quebec) is 13,000 square-feet of class 100 and class 10,000 "clean room" space. This space hosts our materials research, formulation, micro-fabrication, and packaging activities. A further 2,500 square-foot laboratory is dedicated to core programs such as advanced optics and opto-electronics research, reliability testing for materials and devices, as well as materials characterization services. Recognizing the importance of reliability engineering in the development and manufacturing of optical devices, we have developed our own reliability testing laboratories which we believe will allow Lumenon to duplicate both Telcordia and customer test requirements and accelerate certification test cycles. CORE COMPETENCIES The development of optical components is a complex process requiring deep technical knowledge in chemistry, micro-fabrication, optical design, mechanical/packaging design and reliability engineering. To date, Lumenon has successfully developed strong departmental expertise in materials science, micro-fabrication, optical design, mechanical/packaging design and reliability engineering. We are also developing the expertise in opto-electronics needed to produce what we believe will be next generation hybrid products. INDUSTRY SNAPSHOT/MARKET SECTORS The success of our business is dependent upon product sales to telecommunications network system providers. These providers, in turn, are dependent for their business upon orders for fiber optic systems from telecommunications carriers. Business fluctuations affecting service providers and their telecommunication carrier customers have affected and will continue to affect our business. We are currently in a period of industry-wide overcapacity and declining demand for our products, with systems providers continuing to scale back on deployment and equipment manufacturers relying on component inventories to meet reduced demand. Although network deployments were severely curtailed in the years ended June 30, 2001 and 2002, some network deployment activity continues - but driven by new industry criteria, like cost-reduction and enhanced product performance to improve quality of service and reduce provisioning time and operating expenses. These criteria continue to drive improvements in optical systems, such as the development of Reconfigurable Optical Add/Drop Multiplexers (ROADM) equipped with remotely controllable optical switching features. Carriers today are challenged when it comes to "service-on-demand". They incur significant expense every time there is a request to provide a new wavelength through the network. Not only must every internode of the network be manually reconfigured, but every amplification and retransmission point must be recalibrated and re-equalized. The next generation of Dense Wavelength Division Multiplexing (DWDM) will likely be designed with Variable Optical Attenuation Multiplexer (VMUX), Optical Channel Monitor (OCM) and switch functionality, allowing carriers to do system configuration remotely and avoiding time-consuming "truck rolls" through the network. RHK Inc. and Communication Industry Researchers Inc. (CIR) suggest that positive growth in deployment of new optical systems will be stimulated by three factors: 1) exhaustion 2 of excess inventory; 2) conclusion of "fire-sales" of used equipment from defunct competitors; and 3) a plateau in capacity of present networks. Communications technologies have altered how consumers and corporations communicate, retrieve information, transfer data, make purchases or use audio, video and interactive services. Despite the market downturn, rising internet traffic, the proliferation of wireless technology, and the adoption of data intensive applications on telecommunications and cable networks continue to drive the global demand for bandwidth. Optical fiber deployment has increased in response to this pressure, and dense wavelength division multiplexing has emerged as the method of choice to enhance the capacity of fiber to transport information. This market broadly segments into the domains of long-haul, metropolitan/core and metropolitan/access. THE LONG-HAUL MARKET is dominated by a select group of trans-national and global carriers that includes companies like Sprint, Quest and WorldCom. It spans both regional and extended geographic distances (up to thousands of kilometers). Long-haul networks connect to metropolitan area networks to create a "global" connectivity among regional domains. The primary use of these networks is to carry capacity from one metropolitan area to another. Customers in this market segment are very sensitive to equipment performance, capacity and scalability, but less sensitive to cost and volume. THE METROPOLITAN/CORE MARKET is characterized by networks spanning distances of up to hundreds of kilometers. This market typically involves large, concentrated metropolitan areas. Metropolitan core networks bridge the space between long-haul and metropolitan access networks, connecting enterprise/private customers in access networks with long-haul service provider networks. This domain is today's communication network bottleneck. It relies heavily on single wavelength point to point activity transported on single mode fiber. The complexity of these networks results from the large number of different protocols that must be handled and the need to provide and manage customer services quickly. In this market, customers are driven by performance, scalability and added functionality (value added to reduce operational cost). Customers here are more sensitive to cost and volume than their long-haul counterparts. THE METROPOLITAN/ACCESS MARKET is characterized by the widest range of data transmission protocols and infrastructure. Its networks connect the edge of the metropolitan core with the end users. These networks have a high percentage of transient use that requires the capability to offer very low to very high wavelength channel capacities. This emerging market segment is driven by cost, scalability and volume, and is thought to be less sensitive to performance. METROPOLITAN MARKET GROWTH To date, long-haul networks have been the growth opportunities for optical systems and their respective optical components. Though the long-haul market has experienced significant expansion, we believe it is the metropolitan core and access markets that will evolve at a more substantial rate and eventually dominate the optical communications marketplace. This growth will be stimulated by the increased allocation of existing bandwidth to the end-user in metropolitan areas. 3 The deployment of new "last-mile" copper technologies such as Digital Subscriber Lines (DSL) and cable modems enhances network access. In turn, access drives demand for bandwidth that impacts throughout the network. End-user demand for bandwidth will in part hinge upon the ability of a given service provider to offer competitively priced services. However, it is the system providers who are expected to provide efficient transport of communications at all network levels, running from the " big pipe" in long-haul down to the "little pipe" through the last mile that connects end-users to the network. THE LUMENON PLAN INITIAL PRODUCT OFFERING. Our plan of operations for the fiscal year ending June 30, 2003 is to continue to develop our Array Waveguide Grating (AWG) optical chip - a fundamental element of any integrated optics product solution - and to aggressively engage the planar optical components market by fully leveraging the monolithic and hybrid optical and opto-electronic integration of our material platforms. Initially we are producing 16 Channel, 100 GHz DWDM sample devices for evaluation and, in alliance with Poly-Scientific (a division of Northrop Grumman), developing a small footprint ROADM for optical channel assignment. In response to an industry call for increased "optical intelligence" for networks, we are also working with Poly-Scientific on the development of an Optical Channel Monitor (OCM), designed to be the first monitoring product to accommodate both optics and electronics in the same small package. MID-TERM PRODUCT OFFERING. In addition to these initial products, we intend to expand our portfolio over the next few years to include: - Low-cost metropolitan products (including 200 GHz & 400 GHz DWDM, Coarse Wavelength Divisional Multiplexing, Splitters & Couplers); - Higher performance devices with higher channel count and tighter channel spacing (including 32 & 40-channel with 50 GHz and 25 GHz channel spacing); - Increased device functionality (including variable optical attenuator, interleavers, splitters/couplers tunable filters, thermal optic switch); and - Increased levels of integration (including VMUX, dynamic gain flattening filters, optical add/drop multiplexer). STRATEGIC CONSIDERATIONS We believe that the PHASIC(TM) process, combined with our advanced material design capabilities, our manufacturing facility and our dynamic and innovative management and technology teams, position us to become one of the future market leaders in delivering Planar Lightwave Circuit (PLC) solutions to the global communications market. Our key advantages include: INNOVATIVE MATERIALS SCIENCE. Lumenon may be unique in the industry in having its own materials science facility for research and development with an emphasis on specialty optical glasses and processes for PLCs. Lumenon has developed capabilities that allow it to build 4 devices out of a broad range of photonic glasses, including silica, spin-on silicon oxides (silsesquioxanes), sol-gel derived silica, hybrid organic polymer-modified silica, and organic polymers. Each material fabric has identifiable strengths. These strengths are enhanced by juxtaposing different, but complementary, material sets. "SMART" PHOTONIC DEVICES FROM "SMART" MATERIALS. Our process is capable of developing "tunable materials", "smart materials", and "smart photonic devices". We believe that smart devices may ultimately offer technical and commercial advantages (fewer parts, reduced or no electronic control, polarization control). We believe that we are among the first to target smart devices for the development of integrated optics. We are currently developing "smart" thermal optical chips that have the potential to eliminate the need for electronic temperature control, or ease the requirements for active thermal management of some optical chip functions. INNOVATIONS IN PACKAGING. Over the last year we have invested in the development of advanced testing and packaging solutions by developing relationships with third parties. EXECUTIVE OFFICERS OF THE REGISTRANT Our executive officers and their respective ages, as of September 25, 2002, are as follows:

Gary Moskovitz has served as our President and Chief Executive Officer and a director since May 2001 and as our Secretary since June 2001. He has also served as our acting Chief Financial Officer since May 2001. Before joining us, Mr. Moskovitz served as President and Chief Executive Officer of Helisys, Inc., a company in the rapid prototyping systems industry, from 1998 to 2000. Mr. Moskovitz was Executive Vice President and Chief Operating Officer of Quintar Corporation, a company in the electronic printing and networked image server industry, from 1992 to 1998. Dr. Mark P. Andrews has served as our Vice President and Chief Technical Officer and as a director since 1998. From 1998 to June 2001, Dr. Andrews also served as our Secretary. Dr. Andrews served as an Associate Professor in the Department of Chemistry at McGill University from 1990 to 2000. Dr. Andrews is also a member of the Materials Research Society and the International Society for Optical Engineers. 5 EMPLOYEES In the fourth quarter of the fiscal year ended June 30, 2001, we announced a restructuring plan designed to better align our cost structures with continued adverse market conditions, that resulted in reductions in our headcount by approximately 25%. In August 2002, we announced a temporary layoff of 37 employees. Of the 50 people we employed as of August 30, 2002, not including those individuals subject to the temporary layoff, 16 were employed in engineering, test and manufacturing, 19 were employed in research and development and the remainder were employed in sales, marketing and administration. INTELLECTUAL PROPERTY We regard much of our intellectual property as proprietary to us and rely on a combination of patent, trade secret, copyright and trademark law, as well as contracts with third parties, to establish and maintain proprietary rights in our technology and products. We are the co-owner of a United States patent and a pending provisional patent application relating to our technology. There can be no assurance that our patent application, or any others that may be filed in the future, will issue, or that upon issuance, the patents will not be challenged or invalidated. In addition, while we intend to vigorously protect our rights, there can be no assurance that any such measures will be successful. We own a number of registered trademarks, including Lumenon and PHASIC, and have trademark applications pending in the United States. All of our scientists and engineers have executed confidentiality and assignment of invention agreements. In addition, prior to disclosing confidential information to third parties, we generally require the third party to sign confidentiality or other agreements restricting the use and disclosure of our confidential information. MATERIAL AGREEMENTS Lumenon and Poly-Scientific (a division of Northrop Grumman) signed an agreement on March 15, 2002, which defines a framework for co-operation in the joint development and marketing of a ROADM. Pursuant to the agreement, the parties agreed to collaborate to define, develop and introduce various versions of the ROADM to market. In addition, Lumenon and Poly-Scientific have agreed to the joint development and marketing of an OCM. The OCM will be incorporated into the ROADM and will be available as a stand-alone product. COMPETITION A large number of component suppliers produce optical components for DWDM and Coarse Wavelength Division Multiplexing (CWDM) networks in the market. A partial list of suppliers include JDS Uniphase Corp., Gould Fiber Optics, Corning OCA, NTT Electronics Corporation Wave Splitter, Lightwave Microsystems Corp. and Bookham Technology plc. In addition, several equipment providers, such as Lucent Technologies, Inc., Alcatel SA, Cisco Systems, Inc., Nortel Networks Corp., NEC Corp. and Fujitsu Limited, have divisions or companies which produce optical components. We expect competition to increase in the future from existing competitors and from companies that may enter our markets with solutions that 6 may be less costly or provide better performance or features. To be successful, we must continue to respond promptly and effectively to changing customer preferences, feature and pricing requirements, technological change and competitors' innovations. Many of our potential customers have substantial technological capabilities and financial resources. These customers may currently be developing, or may in the future decide to develop or acquire, products or technologies that are similar to or may be substituted for our products. This may diminish purchases of our products. A number of our current and potential competitors have longer operating histories, greater name recognition, access to larger customer bases and significantly greater financial, technical, marketing and other resources than we have. As a result, they may be able to adapt more quickly to new or emerging technologies and changes in customer requirements or to devote greater resources to the promotion and sale of their products. In addition, current and potential competitors may determine, for strategic reasons, to consolidate, to lower the price of their products substantially or to bundle their products with other products, thereby increasing competition for our products. Current and potential competitors have established or may establish financial or strategic relationships among themselves or with existing or potential customers, resellers or other third parties. Accordingly, it is possible that new competitors or alliances among competitors could emerge and rapidly acquire significant market share. Increased competition may result in price reductions, reduced gross margins and loss of market share. We believe that our ability to compete successfully depends on a number of factors, both within and outside of our control. These factors include: - the price, performance and quality of our products and those of our competitors; - the timing and success of new product and feature introductions by us, our customers and our competitors; - the emergence of new standards in the optical communications industry and the development of technical innovations; - the availability of raw materials; - the efficiency of production; - the rate at which our customers integrate our products into their products and the number and nature of our competitors in a given market; - the assertion of intellectual property rights; and - general market and economic conditions. ITEM 2. PROPERTIES We currently lease 53,427 square feet in St-Laurent (Montreal, Quebec), Canada where both our corporate headquarters and our manufacturing and processing facilities are located. Our manufacturing facility features materials preparation, fabrication, packaging, optical test and 7 quality control facilities for our products. Our processing facilities include modified semiconductor processing equipment, such as lithography, etching, and analytical measurement and control equipment. ITEM 3. LEGAL PROCEEDINGS We are the subject of two lawsuits in the Quebec Superior Court by two former employees, one of which was filed on August 8, 2001 claiming illegal dismissal and seeking damages in the amount of CDN$256,917.00 and the right to exercise options for 75,000 shares of common stock, and one of which was filed on August 15, 2001 claiming dismissal without cause and seeking damages in the amount of CDN$145,350.02. While we are unable to predict the outcome of these lawsuits at this time, we believe that the lawsuits are without merit and intend to vigorously defend these lawsuits. We recently settled a third lawsuit by a former employee. ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS No matters were submitted to a vote of security holders during the fourth quarter of the fiscal year ended June 30, 2002 through the solicitation of proxies or otherwise. 8 PART II ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY AND RELATED STOCKHOLDER MATTERS MARKET INFORMATION Our common stock has been quoted on The Nasdaq SmallCap Market under the symbol "LUMM" since June 7, 2002. From July 27, 1998, the day on which trading in our common stock commenced, through January 19, 2000, our common stock was quoted on the OTC Bulletin Board. From January 20, 2000 to March 9, 2000, pending the effectiveness of our registration statement on Form 10, trading in our common stock was reported by the National Quotation Bureau on the pink sheets. From March 10, 2000 through April 12, 2000, our common stock was quoted on the OTC Bulletin Board. From April 13, 2000 through June 6, 2002, our common stock was traded on The Nasdaq National Market. The following table sets out in US dollars the high and low bid prices of our common stock for the two most recent fiscal years.

HOLDERS OF COMMON STOCK On September 27, 2002, there were 136 holders of record of our common stock. DIVIDENDS We have not paid and do not intend to pay cash dividends on our common stock. We currently intend to reinvest earnings, if any, in the development and expansion of our business, and therefore do not anticipate paying any cash dividends in our common stock for at least the next fiscal year. SALES OF UNREGISTERED SECURITIES 9 We did not issue any unregistered securities during the fourth quarter of the fiscal year ended June 30, 2002. ITEM 6. SELECTED FINANCIAL DATA The following table sets forth selected financial data for the periods indicated, which has been derived from our consolidated financial statements prepared in accordance with generally accepted accounting principles in the United States that have been audited by KPMG LLP, Montreal, Canada, for the periods ended June 30, 2002, June 30, 2001, June 30, 2000, June 30, 1999 and from inception to December 31, 1998. Also included in this Annual Report on Form 10-K are financial statements including a consolidated balance sheet for the periods ending June 30, 2002 and 2001, and a consolidated statement of operations for the periods ending June 30, 2002 , 2001 and 2000. The data set forth below should be read in conjunction with our consolidated financial statements and notes thereto and "Management's Discussion and Analysis of Financial Condition and Results of Operations" included elsewhere in this Annual Report on Form 10-K. We changed our fiscal year end from December 31 to June 30, effective in 1999. Our functional and reporting currency is the Canadian dollar. For convenience, our most recent financial information has also been presented in US dollars. The US dollar figures in items 6 and 7 are converted from the Canadian dollar using the noon buying rate for cable transfers in New York City in foreign currency as certified by the Federal Reserve Bank of New York as of June 28, 2002 of CDN$1.5190 per US$1.00. ACCOUNTING STANDARDS/PRACTICES With respect to the consolidated financial statements for the years ended June 30, 2002 and 2001, the audit was conducted in accordance with United States generally accepted auditing standards. With respect to the consolidated financial statements for the year ended June 30, 2000, the audit was conducted in accordance with Canadian generally accepted auditing standards. In our auditor's opinion, these consolidated financial statements present fairly, in all material respects, the consolidated financial position of the Corporation as at June 30, 2002 and June 30, 2001 and the consolidated results of its operations and cash flows for the years ended June 30, 2002, 2001 and 2000 and for the period from inception (March 2, 1998) to June 30, 2002, in accordance with United States generally accepted accounting principles. 10 SELECTED FINANCIAL DATA (In thousands of dollars, except per share amounts)

----------------------------- (1) Amounts shown are net of tax credits and grants. (2) In 2000, we recorded an amount of CDN$217,359 as a result of the issuance of common stock to Molex Incorporated in exchange for services received under the terms of a Teaming Agreement (see note 7(a) to our consolidated financial statements). (3) Includes depreciation of CDN$5.7 million (US$3.8 million) for 2002 compared to CDN$4.9 million for 2001 and a write-down of property and equipment of CDN$1.5 million (US$975,000) for 2002 compared to CDN$2.5 million for 2001. (4) Including interest expense of CDN$1.6 million (US$1.1 million) in 2002 and CDN$2.3 million in 2001, financing charges of CDN$2 million (US$1.3 million) in 2002 and CDN$25.1 million in 2001, interest income of CDN$636,000 (US$418,000) in 2002, CDN$2.1 million in 2001, and lost on foreign exchange of CDN$80,000 (US$53,000) in 2002, compared to CDN$278,000 gain on foreign exchange in 2001. (5) For the five periods presented, Lumenon had a weighted average of 39,412,693, 36,957,777, 25,415,601, 17,480,967 and 14,972,188 issued and outstanding shares, respectively. We have never paid dividends on our common stock. 11 ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS The following discussion and analysis of our financial condition and results of operations should be read in conjunction with "Selected Financial Data" and the financial statements and notes thereto appearing elsewhere in this Annual Report on Form 10-K. OVERVIEW Lumenon changed its fiscal year end from December 31 to June 30, effective in 1999. From inception (March 2, 1998) to December 31, 1998, activities were oriented towards the organization of Lumenon. During the six-month period ended June 30, 1999, key activities included certain financial arrangements entered into in connection with the construction of our pilot plant in Dorval, Quebec, Canada and the acquisition of related capital assets. For the purpose of this Management's Discussion and Analysis, 2002 refers to the fiscal year ended June 30, 2002, 2001 refers to the fiscal year ended June 30, 2001 and 2000 refers to the fiscal year ended June 30, 2000. RECENT DEVELOPMENTS In August 2002, we announced a temporary layoff of 37 employees. Of the 50 people we employed as of August 30, 2002, other than the individuals subject to the temporary layoff, 16 were employed in engineering, test and manufacturing, 19 were employed in research and development and the remainder were employed in sales, marketing and administration. We expect to incur an accounting charge in connection with this layoff. However, the magnitude and timing of the accounting charge will depend upon the duration of the layoff. If the layoff exceeds six months, we estimate that under Quebec law we would be obligated to make severance payments of up to CDN$1.2 million (US$775,400) in the aggregate. Under the terms of a common stock purchase agreement dated as of August 14, 2002, Lumenon has the option to receive a maximum of US$14,000,000 by issuing shares of its common stock in a series of periodic draw-downs of funds. The draw-downs are subject to certain limitations and the fulfillment of certain conditions, including a provision which limits the investor's holdings to 9.999% of the outstanding shares of Lumenon common stock at any given time and the receipt of stockholder approval for draw-downs which will result in the issuance of common stock in excess of 19.9% of the common stock issued and outstanding as of the date of the agreement. These limitations and conditions will limit the amount which Lumenon may draw down from time to time. The price of the shares of common stock to be issued to the investor will be based on a discount of 8% to 13% of the volume weighted average price of the common stock during the draw-down period as defined in the agreement. Lumenon has no obligation to draw down the full amount of the commitment. In connection with this agreement, Lumenon issued warrants to the investor to purchase 280,000 shares of Lumenon's common stock at an exercise price of $0.21 per share. 12 FINANCIAL HIGHLIGHTS IN 2002 On October 9, 2001, we agreed with certain of our investors to amend the terms of the documents related to our July 25, 2000 convertible note financing. The convertible notes were amended and restated to provide for a fixed conversion price of US$1.44 per share, to eliminate certain restrictive covenants and to eliminate certain events of default. As security for the repayment of the amended and restated convertible notes, we granted the investors a security interest in all of our present and future moveable property, rights and assets. This security interest is subordinate to any equipment lease financing or purchase money security interest into which we may enter. In addition, warrants to purchase an aggregate of 5,000,800 shares of common stock issued in the financing were cancelled and the securities purchase agreement and the registration rights agreement were amended to eliminate certain restrictive covenants. During the year 2002, CDN$4.3 million (US$2.9 million) of principal (net of debt discount) and accrued interest of the convertible notes was converted into 2,485,503 shares of common stock. On March 15, 2002, we entered into agreements with Poly-Scientific, a division of Northrop Grumman's Component Technologies sector, to develop and market a ROADM module and to jointly develop and market an optical channel monitor. During the fourth quarter of 2002, we met a milestone under the agreements by delivering our first samples to Northrop Grumman. To date, we have not derived any revenues from our relationship with Northrop Grumman. RESULTS OF OPERATIONS Lumenon is a development stage enterprise which has not realized any revenues from operations. RESEARCH AND DEVELOPMENT EXPENSES COMPARISON OF 2001 TO 2002 Research and development expenses net of tax credit, decreased from CDN$8.3 million in 2001 to CDN$4.1 million (US$2.7 million) in 2002, a decrease of CDN$4.2 million or 51%. This decrease was principally due to reduced spending on materials and supplies for research and development activities of CDN$2.5 million, resulting from the consolidation of the research and development facility in Dorval with our headquarters and manufacturing center in St-Laurent, in August 2001. During 2001, we extended the exercise period for certain outstanding options and reduced senior management functions and employee headcount, resulting in the cancellation of certain outstanding options. As a result, non-cash stock based compensation cost decreased from CDN$1 million in 2001 to CDN$193,00 (US$127,000) in 2002, a decrease of CDN$837,000 or 81%. We recorded research tax credits of CDN$954,000 (US$628,000) in 2002, compared to CDN$113,000 in 2001, an increase of CDN$841,000. As a result of a final tax assessment for 1999 by Canadian federal and provincial taxation authorities and the finalization of our 2001 research and development grant, a credit of CDN$582,000 was recognized in 2002. COMPARISON OF 2000 TO 2001 13 Research and development expenses decreased from CDN$219 million in 2000 to CDN$8.3 million in 2001, a decrease of CDN$210.7 million. This decrease was principally due to a CDN $217.4 million non-cash expense recorded during 2000, which resulted from the issuance of shares of our common stock in consideration of certain services rendered by Molex under the terms of a teaming agreement with Molex pursuant to which we had agreed to jointly develop dense wavelength division multiplexing products. The decrease resulting from a non-cash expense related to stock issuances was partially offset by an increase in the size of our research and development team during 2001 by 22 additional people, resulting in an expense of approximately CDN$574,000. The modification of the exercise period of certain outstanding options granted under our stock option incentive plan from two to five years and the grant of options with a below market value exercise price to certain consultants created a total non-cash compensation expense of CDN$4.9 million, of which CDN$1.0 million was recorded under research and development expenses. There was no significant expense of this nature in 2000. GENERAL AND ADMINISTRATIVE EXPENSES COMPARISON OF 2001 TO 2002 The general and administrative expenses were CDN$25.1 million in 2001 and CDN$16.7 million (US$11 million) in 2002, a decrease of CDN$8.4 million or 33%. During the fourth quarter of 2001, we reduced our workforce and consolidated our facilities in an effort to align our cost structure with prevailing market conditions and to create a more flexible and efficient organization. The decrease in our general and administrative expenses was mainly attributable to the reduction of expenses associated with a restructuring that included a 25% reduction in staff at the end of the fiscal year 2001. As a result, for 2002, salaries, fringe benefits and non-cash compensation decreased by CDN$3.9 million or 47%. Professional fees also contributed to the decrease with a reduction of CDN$2.5 million or 57%. However, depreciation charges increased by CDN$796,000 or 16% during 2002. During the fiscal year ended June 30, 2001, we acquired certain equipment anticipated to be used in production. Subsequently, we concluded that we needed additional time and efforts to complete the development of our initial product and, as a result, the recoverability of plant equipment and laboratory installation to be used in commercial production has been established on fair value under Statements of Financial Accounting Standards, known as SFAS, No. 121 Accounting for the Impairment of Long-Lived Assets and for Long-Lived Assets to Be Disposed of, and a write-down of CDN$2.5 million recorded during 2001. In conjunction with this matter, we recorded an additional write-down of CDN $1.5 million during 2002. COMPARISON OF 2000 TO 2001 The general and administrative expenses were CDN$4.9 million in 2000 and CDN$25.1 million in 2001, an increase of CDN$20.2 million. The increase was mainly attributable to expenses associated with the hiring of 13 administrative employees and the movement of our headquarters to a new facility in St-Laurent (Montreal, Quebec), Canada. As a result of our growth, the depreciation charges increased by CDN$4.0 million during 2001. In addition, during 2001, we acquired certain equipment anticipated to be used in production. Subsequently, we concluded that we needed additional time and efforts to complete the development of our initial product and, as a result, the recoverability of plant equipment 14 and laboratory installation to be used in commercial production has been established on fair value under SFAS, No. 121 and a write-down of CDN$2.5 million was recorded during 2001. Finally, part of the increase in general and administration expenses resulted from a CDN$3.9 million non-cash compensation expense, arising from the modification of the terms of outstanding options granted under our stock option incentive plan to our general and administrative staff and the grant of certain options with a below market value exercise price. For the fiscal period ending June 30, 2003 and moving forward we will comply with the Statement of Financial Standards known as SFAS 144 (Accounting for the Impairment or Disposal of Long-Lived Assets) and SFAS 146 (Accounting for Obligations Associated with Disposal Activities). OTHER EXPENSES OR INCOME COMPARISON OF 2001 TO 2002 Other expenses was CDN$25.0 million in 2001 compared to CDN$3.1 million (US$2.0 million) in 2002, a decrease of CDN$21.9 million or 88%. The decrease is primarily attributable to financing charges related to the beneficial conversion feature of the convertible notes issued on July 25, 2000 and the amortization of the debt discount, a non-cash expense totaling CDN$2.0 million (US$1.3 million) for 2002 compared to CDN$25.1 million for 2001. In addition, the interest expense on the convertible notes amounted to CDN$1.6 million (US$1.1 million) in 2002 compared to CDN$2.3 million in 2001. Our interest income also decreased in 2002 to CDN$636,000 (US$419,000) from CDN$2.1 million, a decrease of CDN$1.5 million or 70% due to the decrease in our cash and short-term investments. Finally, we recognized a loss on foreign exchange of CDN$80,000 (US$53,000) in 2002 compared to a gain of CDN$278,000 in 2001. COMPARISON OF 2000 TO 2001 Other income was CDN$320,000 in 2000 compared to other expenses of CDN$25.1 million in 2001, an increase in expenses of CDN$25.4 million. The increase in expenses is primarily attributable to financing charges related to the beneficial conversion feature of the convertible notes issued on July 25, 2000 and the amortization of the debt discount, a non-cash expense totaling CDN$25.1 million. In addition, the interest expense on the convertible notes amounted to CDN$2.1 million in 2001. The interest income and the gain on foreign exchange also increased in 2001 by CDN$2.0 million due to an increase in cash and short-term investments from equity and debt financing during 2001. In 2000, other income of CDN$320,000 resulted mainly from interest income and gain on foreign exchange. FINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES During the 18 month period ended June 30, 1999, we had been engaged in capital raising, developmental and organizational activities and the construction of our pilot plant in Dorval, Quebec, Canada. In 2000 and 2001, we made significant investments in staffing and equipment. These investments and costs have been financed mainly through proceeds from private placements, the exercise of warrants issued in such private placements and the exercise of stock 15 options. As at June 30, 2002, we had cash and cash equivalents and commercial papers and term deposits of CDN$7.0 million (US$4.6 million) as compared to CDN$22.3 million as of June 30, 2001. We do not believe that inflation has had a significant impact on our results of operations. Cash flows generated from investing activities were CDN$12.7 million (US$8.4 million) for 2002 compared to utilization of CDN$37.1 million in 2001. These cash flows were mainly derived from disposal of commercial papers and term deposits in order to support our operations in St-Laurent (Montreal, Quebec), Canada, our headquarters and manufacturing center. This includes investments of CDN$878,000 (US$578,000) in property and equipment. Cash flows used in financing activities amounted to CDN$1.1 million (US$755,000) for 2002, resulting from repayments of obligations under capital leases. During 2001, cash flows of CDN$53.6 million were mainly generated from the issuance of convertible notes and common stock. Funds raised through our financing activities in 2001 were partially offset by operating expenses amounting to CDN$15.2 million and the acquisition of property and equipment for CDN$22.2 million. If the remaining principal of the convertible notes and unpaid interest calculated at the rate of 7.5% are not converted into additional common stock upon maturity, on July 25, 2005, we will be required to pay an aggregate of CDN$13.7 million (US$9.1 million) plus accrued interest to the noteholders. The convertible notes were amended and restated to provide for a conversion price of US$1.44 per share, to eliminate certain restrictive covenants and to eliminate certain events of default. As security for the repayment of the amended and restated convertible notes, we granted the investors a security interest in all of our present and future moveable property, rights and assets. This security interest is subordinate to any equipment lease financing or purchase money security interest into which we may enter. In addition, the 5,000,800 common stock purchase warrants issued in the financing were cancelled and the securities purchase agreement and the registration rights agreement were amended to eliminate certain restrictive covenants. As of June 30, 2002, we had cash and cash equivalents on hand of CDN$686,000 (US$452,000) as compared to CDN$2.4 million as of June 30, 2001. We also had CDN$6.4 million (US$4.2 million), as compared to CDN$20 million as of June 30, 2001, in commercial paper and term deposits with maturity dates no later than December 31, 2002 and with no restriction in their use. As of June 30, 2002, the market value approximated the carrying value. The Auditors' Report to the Stockholders and the accompanying notes set forth in the financial statements indicate that we have no current source of revenue and that without the realization of additional capital, it would be unlikely for us to continue as a going concern. As a pre-revenue, development stage company, we will require additional funding to maintain operations. If we are unable to obtain an adequate amount of additional funding we will have to delay or abandon some or all of our current and anticipated research and development projects, significantly cut back on our operations, sell some or all of our assets, license potentially valuable technologies that we currently plan to commercialize to third parties or cease operations 16 all together. To that end we have been actively seeking financing and other possible transactions that could raise the substantial additional funding required to meet our future capital needs. We have no other significant financial obligations at June 30, 2002, other than operating lease commitments for our premises and equipment and employment agreements. Minimum lease payments under capital lease, operating lease agreements and convertible notes for the next 5 years and thereafter are presented as follows:

CRITICAL ACCOUNTING POLICIES Our discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Areas where significant judgments are made include, but are not limited to, the Impairment of Long-Lived Assets. Actual results could differ materially from these estimates. Impairment of Long-Lived Assets. In fiscal 2001, Lumenon concluded it required additional time and effort to complete the development of its products, and as a result, commencement of production was delayed. In addition, in response to a perceive market downturn for optical circuits, Lumenon re-focused its process of providing only simple passive components to one of offering a mix of products and services ranging from optical chips to integrated photonic solutions. As a result, management decided to segregate the assets to be used in production from those that will not be used in the future. In establishing recoverable value of property, plant and equipment, management made estimates about future cash flows to be generated from the sale of the assets. Fair value has been established under SFAS, No. 121, and because we are a development stage enterprise, recoverability is based on information obtained from suppliers and other companies operating in the same field of activities. As a result, a decrease in value of certain equipment was reflected by a write-down and the equipment for which management believes there will be no future use due to technological changes were written-off. 17 RISK FACTORS Investing in our common stock involves a high degree of risk. You should carefully consider the risks and uncertainties described below before purchasing our common stock. The risks and uncertainties described below are not the only ones facing our company. Additional risks and uncertainties may also impair our business operations. If any of the following risks actually occur, our business, financial condition or results of operations would likely suffer. In that case, the trading price of our common stock could fall, and you may lose all or part of the money you paid to buy our common stock. RISKS RELATED TO OUR BUSINESS AND INDUSTRY IN ORDER TO REMAIN IN BUSINESS, WE MUST OBTAIN ADDITIONAL FUNDING TO MEET OUR FUTURE CAPITAL NEEDS. IF WE ARE UNABLE TO OBTAIN SUCH FINANCING, WE WILL BE REQUIRED TO DELAY OR ABANDON SOME OR ALL OF OUR ANTICIPATED RESEARCH AND DEVELOPMENT PROJECTS, SIGNIFICANTLY CUT BACK OUR OPERATIONS, SELL ASSETS OR LICENSE POTENTIALLY VALUABLE TECHNOLOGIES TO THIRD PARTIES OR CEASE OPERATIONS. The auditors report covering our audited financial statements which are included in our Annual Report on Form 10-K for the year ended June 30, 2002 contained going concern modifications. Our auditors noted that we have no current source of revenue and without the realization of additional capital, it would be unlikely that we will be able to continue our business as a going concern. In order to remain in business, we will require substantial additional funding over the next several years to develop our technology, to broaden and commercialize our products and to expand our manufacturing capacity. Despite the fact that we have recently entered into $14 million equity line financing agreement with Crossover Ventures, amounts available under the equity line may not be sufficient to meet our cash needs in the future. In addition, business and economic conditions may make it unfeasible or undesirable to draw down under the agreement at every opportunity, and only one draw down may occur at a time. Additional funding may be unavailable on favorable terms, or not be available at all. If we are unable to obtain sufficient additional funding, we will have to delay or abandon some or all of our current and anticipated research and development projects, significantly cut back our operations, sell some or all of our assets, license potentially valuable technologies to third parties that we currently plan to commercialize ourselves or cease operations. To date, we have received approximately CDN$71.6 million from third parties through various debt and equity financings. If we borrow more funds, we may become subject to restrictive financial covenants and our interest obligations will increase. In addition, if we raise additional capital by issuing additional equity securities, our existing stockholders would suffer substantial dilution. WE ARE A DEVELOPMENT STAGE COMPANY WITH NO EXPERIENCE IN MANUFACTURING AND MARKETING OUR PRODUCTS, MAKING IT DIFFICULT TO EVALUATE OUR BUSINESS AND YOUR INVESTMENT. We have no history in manufacturing and marketing our products. We are a development stage company and, to date, have not had any revenues from sales of our products. Our operating history provides no basis for evaluating us or our prospects. We must successfully 18 develop and manufacture our products, address our competition, attract, retain and motivate qualified employees, expand our operations and market and sell products in large volumes to have significant revenues and to become profitable. We have operated as a development stage company for an extended period of time and there is no assurance that we will be successful in creating products or processes that provide the stability, reproducibility, reliability and performance to be transferred into commercial production. Our future success will depend on our ability to develop, manufacture and commercialize products based upon our licensed proprietary technologies. Potential customers may not accept our products and these products may be difficult to produce in large volumes, fail to perform as expected, cost too much to produce or be barred from production by the proprietary rights of others, which would delay or prevent us from having significant revenues or from becoming profitable. WE HAVE A HISTORY OF LOSSES, WE EXPECT FUTURE LOSSES AND OUR FUTURE PROFITABILITY IS UNCERTAIN. We have incurred operating losses since our inception and, as of June 30, 2002, had an accumulated deficit of approximately CDN$307 million (US$202 million). We expect to spend substantial funds to continue research and product development, to establish sales, marketing and quality control departments and for other general corporate purposes. Over at least the next several years, we expect to continue incurring considerable operating losses and negative cash flows as we incur significant operating expenses and make capital expenditures in our business. The amount we will lose and when, if ever, we will have profits is highly uncertain. If we are unsuccessful at developing, manufacturing and marketing our products, we will not generate sufficient revenues to become profitable. Even if we do become profitable, we may not be able to sustain or increase profitability on a quarterly or annual basis. If we fail to become and remain profitable, the market price of our common stock will decline. IF THE PRICE OR THE TRADING VOLUME OF OUR COMMON STOCK DOES NOT REACH CERTAIN LEVELS, WE WILL BE UNABLE TO DRAW DOWN ALL OR SUBSTANTIALLY ALL OF THE $14 MILLION UNDER OUR EQUITY LINE, WHICH MAY FORCE US TO SIGNIFICANTLY CURTAIL THE SCOPE OF OUR OPERATIONS AND ALTER OUR BUSINESS PLAN. The maximum amount of a draw down under our equity line facility will be equal to 10% of the weighted average price for our common stock for the 60 trading day period immediately prior to the first day of the pricing period specified in the notice to Crossover of our intention to exercise a draw down multiplied by the total trading volume with respect to our common stock for such period. If our stock price and trading volume falls below certain levels, then either the maximum draw down amount formula or the mandatory threshold price will probably prevent us from being able to draw down all $14 million pursuant to the proposed equity line facility with Crossover. For example, during the 60 trading day period ended September 20, 2002, our weighted average stock price was $0.212 per share and our total daily trading volume was 8,803,500 shares. Based on this stock price and trading volume, the maximum draw down amount available to us during such period would have been $186,106. Accordingly, our stock price and the trading volume of our stock will have to increase substantially in the future in order for us to have access to the full $14 million under the equity line. If we are unable to draw down 19 the full $14 million, we may have to curtail the scope of our operations as contemplated by our business plan. THE COMMON STOCK PURCHASE AGREEMENT WITH CROSSOVER LIMITS THE NUMBER OF SHARES OF COMMON STOCK CROSSOVER IS REQUIRED TO HOLD AT ANY ONE TIME TO 9.999%, WHICH MAY FURTHER LIMIT OUR ABILITY TO DRAW DOWN AMOUNTS THAT WE REQUEST AND WHICH MAY CAUSE US TO SIGNIFICANTLY CURTAIL THE SCOPE OF OUR OPERATIONS AND ALTER OUR BUSINESS PLAN. The common stock purchase agreement we have entered into with Crossover in connection with the equity line facility provides that we may not sell shares of our common stock pursuant to our draw down right under that agreement if the sale would cause the Crossover to beneficially own more than 9.999% of our issued and outstanding common stock at any one time. Accordingly, we may have to significantly curtail the scope of our operations and alter our business plan if, at the time of one or more draw downs, this 9.999% restriction results in our inability to draw down some or all of the amounts requested in any draw down notice. Any resale of our common stock by Crossover would reduce Crossover's beneficial ownership, reducing the effect of the 9.999% provision on our ability to exercise drawdowns, but also likely have a dilutive effect on the price of our common stock. WE MAY USE THE PROCEEDS OF OUR EQUITY LINE FINANCING IN WAYS WITH WHICH YOU MAY NOT AGREE. Net proceeds to us from any sales to Crossover will be used principally for the continued development and implementation of our technology, advertising and marketing and for general corporate purposes. We have not allocated any specific amount of our net proceeds for any particular purpose. Consequently, our management will have broad discretion with respect to the expenditure of the net proceeds of any sales to Crossover, including discretion to use the proceeds in ways with which you may not agree. THE TELECOMMUNICATIONS INDUSTRY IS CURRENTLY EXPERIENCING A CHALLENGING PERIOD AND WILL FOR THE FORESEEABLE FUTURE CONTINUE TO EXPERIENCE THE EFFECTS OF THE MARKET DOWNTURN. FLUCTUATIONS IN INDUSTRY DEMAND FOR OPTICAL COMPONENTS CREATE SIGNIFICANT UNCERTAINTIES IN OUR BUSINESS, WHICH COULD HAVE A MATERIAL ADVERSE IMPACT ON OUR RESULTS OF OPERATIONS. The success of our business is dependent upon product sales to telecommunications network system providers. These providers, in turn, are dependent for their business upon orders for fiber optic systems from telecommunications carriers. Business fluctuations affecting service providers and their telecommunication carrier customers have affected and will continue to affect our business. We are currently in a period of industry-wide overcapacity and declining demand for our products, with systems providers continuing to scale back on deployment and equipment manufacturers relying on component inventories to meet reduced demand. This downturn in the industry is characterized by inventory overcapacity and reduced revenues, which at times may, if the downturn is sufficiently prolonged or severe, force system providers and telecommunications carriers to reduce expenditures on our technology and products. In addition, due to the lead times associated with the production of telecommunications equipment, a rise or fall in the level of sales of telecommunications equipment typically lags any downturn or recovery in the telecommunications market by approximately six to twelve months. Our success depends upon 20 increasing demand for products that incorporate our technology and the continued downturn in the industry has and will continue to negatively impact our business and results of operations. IF WE FAIL TO DEVELOP AND MAINTAIN RELATIONSHIPS WITH EQUIPMENT PROVIDERS WHO INCORPORATE OUR PRODUCTS INTO THEIRS, OUR REVENUES WILL SUFFER. We rely on equipment manufacturers to sell our products as part of an integrated offering. We do not have agreements with any of these equipment manufacturers. Our business may be adversely affected if these equipment manufacturers change their business priorities or experience difficulties in their operations or choose to incorporate another company's products into their integrated offerings. In addition, we must enter into additional relationships with other equipment providers in order to be successful. If we fail to enter into or maintain such relationships, our business, operations and financial condition could be harmed. THERE ARE SIGNIFICANT RISKS ASSOCIATED WITH THE MANUFACTURE OF OUR PRODUCTS. We must effectively transfer production information from our research and product development departments to our manufacturing facility and rapidly achieve volume production. If we fail to manage this process effectively, the shipments of products to our customers could be delayed which could damage our reputation and cause us to lose customers. In addition, we have never assembled large amounts of our products. The manufacture of our chips and packaged components is a complex, sophisticated process, requiring a clean room and precision assembly equipment. Very small amounts of contaminants during assembly, defects in components, difficulties in the assembly process or other factors could cause a significant number of our products to be nonfunctional or to have unacceptable defects. Because most of our manufacturing costs are relatively fixed, manufacturing yields are critical to the results of our operations. Lower than expected manufacturing yields could delay product shipments and reduce our gross margins. Addressing any of these problems could require a significant amount of time and resources to correct, which could delay the shipment of products to our customers, which could damage our reputation, cause us to lose customers or hinder our ability to attract new customers or achieve market acceptance, which could significantly reduce manufacturing yields. IN ORDER TO REACH PROFITABILITY, WE MUST EXPAND OUR BUSINESS OPERATIONS RAPIDLY AND THE FAILURE TO MANAGE THIS EXPANSION EFFECTIVELY, AS WELL AS THE STRAIN ON OUR RESOURCES WHICH EXPANSION MAY CREATE, COULD IMPAIR OUR ABILITY TO OPERATE PROFITABLY. Our success will depend on the expansion of our operations and the effective management of our growth, which will place a significant strain on our management, operations and financial resources. In particular, once we begin volume assembly of our products, our operations are anticipated to expand substantially. We must hire and train additional scientists, chemists and engineers, manufacturing, marketing, sales and administrative and management personnel and acquire additional equipment, facilities, information technology and other infrastructure. We must also continue to develop our management, operational and financial systems, procedures and controls. Because we have no history with the assembly, marketing or sale of our products in large quantities, we do not know if we will be able to expand our business 21 rapidly or adequately enough to manage this growth. If we do not accurately predict demand for our products, we may have too much or too little production capacity. In addition, if we overestimate demand, we may incur fixed production expenses that could be excessive in relation to revenues generated. This would reduce our gross margins and increase our net loss. If we underestimate demand and as a result, are not able to respond to the needs of our customers, we may lose customers, which would decrease our revenues. CREATING INTERNATIONAL SALES AND MANAGING INTERNATIONAL OPERATIONS WILL BE DIFFICULT AND OUR FAILURE TO DO SO SUCCESSFULLY COULD AFFECT OUR ABILITY TO BECOME PROFITABLE OVER THE LONG TERM. Currently, we have a limited international presence on which to base our expectations for international sales, however, we believe that in order to achieve our long-term business goals, we will have to generate sales in international markets. This will require us to establish international operations and hire additional personnel. Our failure to do so in a timely and effective manner could have a material adverse effect on our business, prospects, financial condition and operating results. Our plans to expand internationally may be affected by a number of risks including: - changes in foreign currency exchange rates; - challenges inherent in managing geographically dispersed operations; - multiple, conflicting and changing governmental laws and regulations; - political and economic instability or conflicts; - changes in tariffs, taxes and other trade barriers - lack of experience in a particular geographic market; - significant presence of our competitors in international markets; - inability to recruit personnel in a specific country or region; and - the need to develop local distribution channels through third parties. THE MARKETS IN WHICH WE COMPETE ARE HIGHLY COMPETITIVE AND SUBJECT TO RAPID TECHNOLOGICAL CHANGE; WE MAY NOT BE ABLE TO COMPETE SUCCESSFULLY IF WE ARE UNABLE TO ADAPT TO NEW TECHNOLOGIES AND SUCCESSFULLY DEVELOP NEW AND EVOLVING PRODUCTS, WHICH MAY LEAD TO REDUCED SALES OF OUR PRODUCTS, REDUCED REVENUES AND REDUCED MARKET SHARE. We must become a key supplier of components to the photonics industry to be successful. The photonics market is highly competitive and subject to continuous, rapid technological change, including changing industry standards, frequent introduction of new products, anticipated and unanticipated decreases in average selling prices and fierce price competition. As a result, our core technology faces competition from new and revised technologies that may render our existing technology less competitive or obsolete. We may be unable to adapt to the rapid technological change exhibited in this market place. 22 In order to be successful, we must: - anticipate what features and functions our customers and their end-users will need and demand in our products, for both general industry and specific custom-made use; - incorporate those features and functions into our products; - meet specific and exacting design requirements; and - price our products competitively. If we fail to anticipate or respond adequately to technical developments or customer requirements, our business and operating results will be negatively impacted. In addition, due to the constant change in the technology environment, the life cycle of the products we make may be short. We must introduce new products on a timely basis. Due to the complexity of our products, we could experience delays in introducing new products. If we experience significant delays in product development or introduction, our business operating results will be negatively impacted. In addition, to the extent we determine that new technologies are required to remain competitive, the development and implementation of such technologies may require us to make significant capital investments. We may not be able to obtain capital for these purposes and investments in such technologies may not result in commercially viable technological products. The loss of revenue and increased costs to us from such changing technologies would adversely affect our business. THE SMALL NUMBER OF POTENTIAL CUSTOMERS FOR OUR PRODUCTS WILL GIVE THESE CUSTOMERS CONSIDERABLE LEVERAGE OVER US, WHICH COULD LEAD TO LOWER SALES PRICES. For the foreseeable future, we expect to market our products to a relatively limited number of leading original equipment manufacturers. We will rely on these customers to develop their own systems, thereby creating demand for our products. As a result of the limited number of customers and the intense competition in the market, our customers will exert considerable leverage in negotiating purchases from us, which could lead to lower sales prices. OUR COMPETITORS MAY BE ABLE TO DEVELOP AND MARKET THEIR PRODUCTS MORE EFFECTIVELY THAN WE CAN, MAKING OUR PRODUCTS OBSOLETE. Our competitors include much larger companies that have substantially greater financial, technical, marketing, distribution and other resources, broader product lines, greater name recognition and longer standing relationships with leading original equipment manufacturers than we do. Our competitors include companies already manufacturing large volumes of products based on established technologies, as well as companies selling emerging technological solutions, which could replace the technologies we are currently using. Potential competitors could also include our own customers, which may decide to manufacture products competitive with ours, rather than purchase our products. As a result, the market for optical circuit technology has become and continues to be intensely competitive. Some competitors have 23 become more aggressive with their pricing, payment terms and/or issuance of contractual implementation terms or guarantees. We may not be able to compete successfully with new and existing competitors without lowering prices or affecting other favorable terms. We expect competition to persist and intensify, which could affect our ability to commercialize our products, which would negatively impact our future operating results. IF OUR RECENT TEMPORARY LAYOFF OF EMPLOYEES BECOMES PERMANENT, WE MAY BE OBLIGATED TO MAKE A SUBSTANTIAL SEVERANCE PAYMENT TO THESE EMPLOYEES. In August 2002, we announced a temporary layoff of 37 employees. Of the 50 people we employed as of August 30, 2002, other than the individuals subject to the temporary layoff, 16 were employed in engineering, test and manufacturing, 19 were employed in research and development and the remainder were employed in sales, marketing and administration. We expect to incur an accounting charge in connection with this layoff. However, the magnitude and timing of the accounting charge will depend upon the duration of the layoff. If the layoff exceeds six months, we estimate that under Quebec law we would be obligated to make severance payments of up to CDN$1.2 million (US$775,400) in the aggregate. WE ARE DEPENDENT ON KEY PERSONNEL TO OPERATE OUR BUSINESS. WE MAY NOT BE ABLE TO ATTRACT, TRAIN AND RETAIN SUFFICIENTLY QUALIFIED PERSONNEL, WHICH COULD LIMIT OUR ABILITY TO GROW OUR BUSINESS. Our success will depend to a significant degree upon the continued services of key management, technical, and scientific personnel, including Gary Moskovitz, our President and Chief Executive Officer, and Dr. Mark P. Andrews, our Co-founder, Vice President of Technology and Chief Technology Officer. We do not currently maintain key-man life insurance for any of our personnel. Our success will also depend on our ability to attract, train and retain additional management and other highly skilled technical, and support personnel. In addition, as we grow, we will need to hire skilled operators for our assembly process. Our competitors for qualified personnel are often long-established, highly profitable companies. As a result, we may have to grant large numbers of options or other stock-based awards to attract and retain personnel, which could be highly dilutive to our stockholders. In addition, our future profitability will also depend on our ability to develop an effective marketing staff and field sales force. Competition for employees with sales and marketing experience in the photonics industry is intense. We require sales people with a good technical understanding of our products and of the industry and the failure to attract, train and retain such personnel could negatively impact our development and manufacturing goals and the effectiveness of our sales and marketing efforts. IF WE FAIL TO ADEQUATELY PROTECT OUR INTELLECTUAL PROPERTY RIGHTS OR FACE A CLAIM OF INTELLECTUAL PROPERTY INFRINGEMENT BY A THIRD PARTY, THEN WE COULD LOSE VALUABLE INTELLECTUAL PROPERTY RIGHTS, BE LIABLE FOR SIGNIFICANT DAMAGES OR BE PREVENTED FROM COMMERCIALIZING OUR PRODUCTS. Our success depends in part on our ability to obtain and maintain patents, protect trade secrets and operate without infringing upon the proprietary rights of others. In the absence of patent and trade secret protection, competitors may adversely affect our business by 24 independently developing and marketing substantially equivalent products and technology and preventing us from marketing our products. It is also possible that we could incur substantial costs in litigation if we are required to defend ourselves in patent suits brought by third parties, or if we are required to initiate litigation against others to protect our intellectual property rights. We may not be issued patents based on the applications already filed or that we file in the future, and if patents are issued, they may be insufficient in scope to cover the products we hope to market. Moreover, legal standards relating to the scope and validity of patent claims are evolving. Any patents we have obtained, such as our patent for the method of "on-substrate cleaving of sol-gel waveguide", or that we may obtain in the future, may be challenged, invalidated or circumvented. Moreover, the United States Patent and Trademark Office may commence interference proceedings involving our patents or patent applications. Any challenge to, or invalidation or circumvention of, our patents or patent applications could have a material adverse effect on our business. If we are required to defend ourselves against patent suits brought by third parties and we do not prevail, in addition to any damages we might have to pay, any patents we may obtain could be narrowed, invalidated or rendered unenforceable by a court. We could also be required to design around any patents we are deemed to infringe or obtain a license to use certain technologies. If we fail to obtain a required license on a cost-efficient or on an exclusive basis or are unable to design around a patent, we may be unable to sell some of our products, which would make it more difficult for us to achieve profitability. We also rely on trade secret and copyright law and employee and third-party nondisclosure agreements to protect our intellectual property rights. We may be unable to secure meaningful protection of our trade secrets, copyrights, know-how or other proprietary information in the event of infringement by others or if others independently develop similar technologies. WE ARE DEPENDENT ON EQUIPMENT SUPPLIERS AND CONTRACT MANUFACTURERS WHO COULD DISRUPT OUR BUSINESS IF THEY STOPPED, DECREASED OR DELAYED SHIPMENTS TO US. We rely on outside suppliers to provide some of the equipment we use in our manufacturing process. We do not maintain long-term agreements with any of these suppliers and, therefore, they could stop supplying equipment to us at any time. If the equipment, which any particular supplier provides to us, were to malfunction or were not supplied to us, we would, at a minimum, experience delays in the shipment of our products and we could be required to find another equipment supplier. In addition, we may rely on third party manufacturers to produce some of the components used in our products. Our potential dependence upon third party manufacturing relationships could lead to: - reduced control over equipment delivery schedules; - lack of quality assurance over the components produced by third parties; and 25 - the delivery of poor quality components which could lead to poor manufacturing yields of our products and ultimately higher product costs. Any supply deficiencies relating to the quality or quantity of equipment or components we use to manufacture our products could affect our ability to fulfill customer orders and ultimately reduce our revenues and profitability. SEVERAL OF OUR AGREEMENTS CONTAIN TERMS WHICH WILL REDUCE THE AMOUNT OF REVENUES THAT WE WILL RECEIVE UPON THE SALE OF OUR PRODUCTS AND THIS MAY DECREASE OUR PROFITABILITY. To date, we have not had any material revenues from product sales. However, our agreements with Polaroid Corporation, Polyvalor and McGill University require that we pay a royalty based upon our gross sales. In the event that we do generate revenues, those agreements require us to allocate a percentage of our revenues to third parties, which may ultimately lower our gross margin and ultimately, our net income. OUR BUSINESS INVOLVES THE USE OF SOME HAZARDOUS MATERIALS AND ENVIRONMENTAL LAWS AND REGULATIONS MAY EXPOSE US TO LIABILITY AND THEREFORE INCREASE OUR COSTS. We handle small amounts of hazardous materials as part of our manufacturing activities. As a result, our operations and assembly processes are subject to certain federal, provincial and local environmental protection laws and regulations. These relate to our use, handling, storage, discharge and disposal of certain hazardous materials and wastes, the pre-treatment and discharge of process waste waters and the control of process air pollutants. Compliance with these laws and regulations requires us to establish compliance procedures and safety programs. If environmental laws or regulations were to change, forcing us to modify production processes or use more costly materials, our manufacturing costs or product sales could be adversely affected. We may be required to incur additional costs to comply with current or future environmental laws. In addition, if we fail to comply with either present or future environmental regulations, we may be subject to fines and production halts. As with other companies engaged in manufacturing activities that involve hazardous materials, the risk of environmental liability is inherent in our manufacturing activities. The costs associated with environmental compliance or remediation efforts or other environmental liabilities could adversely affect our business. TERRORIST ATTACKS AND THREATS OR ACTUAL WAR MAY NEGATIVELY IMPACT ALL ASPECTS OF OUR OPERATIONS, REVENUES, COSTS AND STOCK PRICE. Recent terrorist attacks in the United States, as well as any future events occurring in response to or in connection with them, including, without limitation, future terrorist attacks against United States targets, rumors or threats of war, actual conflicts involving the United States or its allies or military or trade disruptions impacting our domestic or foreign suppliers, may substantially negatively impact our operations. Any of these events could cause consumer confidence and spending to decrease or result in increased volatility in the United States and worldwide financial markets and economy. They also could result in economic recession in the United States or abroad. Any of these occurrences could have a significant negative impact on our operating results, revenues and costs. 26 RISKS RELATED TO OUR CORPORATION OUR COMMON STOCK MAY BE DELISTED FROM THE NASDAQ SMALLCAP MARKET. On June 7, 2002, the listing of our common stock was transferred from The Nasdaq National Market to The Nasdaq SmallCap Market. This transfer allowed our common stock to continue trading on an electronic, well-regulated market and provided us with a grace period until February 10, 2003 to comply with the $1.00 minimum bid price required by the Nasdaq Stock Market, Inc. If we are delisted from the Nasdaq SmallCap Market, our common stock would be likely traded on the "pink sheets" or the Over-The-Counter Bulletin Board. If our common stock were delisted from The Nasdaq SmallCap Market, it could materially adversely affect the market price and liquidity of our common stock and our ability to raise necessary capital. The issuance by us of shares of common stock to Crossover pursuant to the terms of the equity line financing with Crossover, or the subsequent resale by Crossover of those shares, may further reduce the trading price of our common stock. If our common stock were delisted from The Nasdaq SmallCap Market, we would not be able to draw down any additional funds on the equity line with Crossover. In addition, if after December 31, 2002 we are not listed on The Nasdaq National Market for an aggregate of ten trading days, we will be in default of our outstanding convertible notes and the holders of these notes would be entitled to redeem these notes. As of June 30, 2002, the aggregate principal and interest accrued under the notes was $9.1 million. PROVISIONS OF OUR CORPORATE DOCUMENTS AND APPLICABLE LAW MAY PREVENT OR HINDER A CHANGE OF CONTROL. Provisions of our certificate of incorporation and by-laws and of applicable law could make it more difficult for another party to acquire us or discourage another party from attempting to acquire us. This may reduce the value of our common stock. For example, we could issue preferred stock with rights senior to the common stock without any further vote or action by stockholders. The issuance of preferred stock as part of a future financing could have the effect of preventing a change of control and could make it more difficult for holders of our common stock to take certain corporate actions, including replacing incumbent directors. Additionally, the preferred stock may have preference over, and harm the rights of the holders of, our common stock. WE HAVE A SIGNIFICANT NUMBER OF OUTSTANDING CONVERTIBLE NOTES, WARRANTS AND OPTIONS, THE EXERCISE OR CONVERSION OF WHICH COULD DECREASE THE PRICE OF OUR COMMON STOCK. To date, we have issued numerous warrants, options and convertible notes, which are exercisable or convertible into shares of our common stock. Holders of our common stock could experience substantial dilution upon the conversion or exercise of outstanding convertible notes, warrants or options. No holder may convert any portion of our outstanding convertible notes to the extent that the conversion would result in that holder or any of its affiliates beneficially owning more than 27 4.99% of our outstanding common stock. Therefore, a holder may have to sell shares of common stock in order to be able to convert those notes. The exercise of outstanding options and warrants and the conversion of outstanding notes will dilute the then current stockholders' ownership of common stock. Sales in the public market of common stock acquired upon exercise of options and warrants and conversions of notes could depress the price of our common stock. This may adversely affect our ability to sell common stock. OUR COMMON STOCK PURCHASE AGREEMENT WITH CROSSOVER VENTURES AND THE ISSUANCE OF SHARES TO CROSSOVER UNDER THAT AGREEMENT MAY CAUSE SIGNIFICANT DILUTION TO OUR STOCKHOLDERS AND MAY HAVE AN ADVERSE IMPACT ON THE MARKET PRICE OF OUR COMMON STOCK. The resale by Crossover of the common stock that it purchases from us will increase the number of our publicly traded shares, which could depress the market price of our common stock. Moreover, as all the shares we sell to Crossover will be available for immediate resale, the mere prospect of our sales to it could depress the market price for our common stock. The shares of our common stock issuable to Crossover under the equity line facility will be sold to Crossover at 87%-92% of the volume weighted average price of our common stock. If we were to require Crossover to purchase our common stock at a time when our stock price is low, our existing common stockholders will experience substantial dilution. The issuance of shares to Crossover will therefore dilute the equity interest of existing stockholders and could have an adverse effect on the market price of our common stock. The perceived risk of dilution may cause our stockholders to sell their shares, which would contribute to a downward movement in the stock price of our common stock. Moreover, the perceived risk of dilution and the resulting downward pressure on our stock price could encourage investors to engage in short sales of our common stock. By increasing the number of shares offered for sale, material amounts of short selling could further contribute to progressive price declines in our common stock. ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK Certain options and warrants are exercisable in US dollars and payable in such currency. Convertible notes are also payable in US dollars. Ultimate proceeds upon exercise of options and warrants as well as repayment of convertible notes, if any, may vary due to fluctuations in the value of the Canadian dollar relative to the US dollar. Market risk is the potential loss arising from adverse changes in market rates and prices, such as foreign currency exchange rates. To the extent that we consummate financings outside of Canada, we receive proceeds in currency other than the Canadian dollar. Currently we have minimal monetary assets, liabilities and operating expenses that are denominated at currencies other than the Canadian dollar. We do not enter into derivatives or other financial instruments for trading or speculative purposes, nor do we enter into financial instruments to manage and reduce the impact of changes in foreign currency exchange rates. If our international operations expand and we decide to enter into hedging transactions to minimize 28 foreign currency exchange rate risk, the adoption of SFAS, No. 133, as amended by SFAS, Nos. 137 and 138, could have a material impact on our operating results. We do not utilize any derivative security instruments. Investments with original maturities of three months or less are classified as cash and cash equivalents. As of June 30, 2002, we consider the reported amounts of these investments to be reasonable approximations of their values. Therefore, changes in market interest rates will not have a material impact on our financial position. Through June 30, 2002, interest expense was not sensitive to the general levels of United States interest rates because all of our notes payable bear fixed interest rates. EXCHANGE RATE INFORMATION Our functional and reporting currency is the Canadian dollar. The table below sets forth, for the periods and dates indicated, information concerning the noon buying rates for the Canadian dollar per US$1.00. The rate reflects the noon buying rate for cable transfers in New York City in foreign currencies as certified by the Federal Reserve Bank of New York. The average consists of the average noon buying rates on the last day of each full month during the indicated period.

ITEM 8. FINANCIAL STATEMENTS See Index to Financial Statements. ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE None. 29 PART III ITEM 10. DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT See "Executive Officers of the Registrant" in Part I of this Annual Report on Form 10-K. DIRECTORS OF THE REGISTRANT We have a classified board of directors consisting of two class I directors, two class II directors and three class III directors. The class I, class II and class III directors serve until the annual meeting of stockholders to be held in 2003, 2004 and 2002, respectively, and until their respective successors are elected and qualified. At each annual meeting of stockholders, directors are elected for a full term of three years to succeed those whose terms are expiring. Set forth below for each member of our board of directors is information concerning his principal occupation and business experience for at least the past five years, the names of other public reporting companies of which he serves as a director and his age and length of service as one of our directors. There are no family relationships among any of our directors and executive officers. Class I Directors (Terms expire at 2003 annual meeting) Pierre-Paul Allard, age 43, has served as a director since 1999. He has served as President and Chief Executive Officer of Cisco Systems Canada Co., the Canadian operation of Cisco Systems Inc., and as Managing Director and in other executive capacities at Cisco Systems Canada Co. since 1993. Pierre-Andre Roy, age 61, has served as a director since 2001. He served as President of Bombardier Capital from 1995 until his retirement in February 2000 and as Treasurer of Bombardier Inc. from 1995 to 1996. Class II Directors (Terms expire at 2004 annual meeting) Guy Brunet, age 50, has served as a director since 2000. Mr. Brunet has served as Branch Manager at Canaccord Capital Corporation, a venture capital firm, since April 2000 and as Investment Advisor for RBC Dominion Securities, an investment banking firm, from 1996 to 2000. Michael G. Wong, age 52, has served as a director since April 2002. Mr. Wong has served as Vice President, IBM Canada since 1997 and has responsibility for IBM's largest microchip packaging facility located in Bromont, Quebec. Class III Directors (Terms expire at 2002 annual meeting) Mark P. Andrews, age 51, has served as a director and as our Vice President and Chief Technical Officer since 1998. From 1998 to 2001, Dr. Andrews also served as our Secretary. Dr. Andrews served as an Associate Professor in the Department of Chemistry at McGill University from 1990 to 2000 and is currently on a leave of absence from that 30 position. Dr. Andrews is also a member of the Materials Research Society and the International Society for Optical Engineers. Gilles Marcotte, age 63, has served as a director since 2000 and as the chairman of the board since 2001. Mr. Marcotte was a partner at KPMG LLP and its predecessor firms from 1979 until his retirement in 1997. Gary S. Moskovitz, age 55, has served as a director and as our President and Chief Executive Officer since May 2001 and as our Secretary since June 2001. He has also served as our acting Chief Financial Officer since May 2001. Before joining us, Mr. Moskovitz served as President and Chief Executive Officer of Helysis, Inc., a company in the rapid prototyping systems industry, from 1998 to 2000. Mr. Moskovitz was Executive Vice President and Chief Operating Officer of Quintar Corporation, a company in the electronic printing and networked image server industry, from 1992 to 1998. SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE Section 16(a) of the Securities Exchange Act of 1934 requires our directors, executive officers and holders of more than 10% of our common stock, collectively referred to as reporting persons, to file with the Securities and Exchange Commission initial reports of ownership and reports of changes in ownership of our common stock and other equity securities. Based solely on our review of copies of Section 16(a) reports filed by the reporting persons and furnished to us, we believe that during fiscal 2002, all filings required to be made by our reporting persons were timely made in accordance with the requirements of the Securities Exchange Act of 1934, other than as follows. Mr. Marcotte filed an amended Form 4 in October 2001 to report a purchase of common stock as a series of separate transactions on a single day rather than as a single transaction on that day. 3474445 Canada Inc. inadvertently omitted to timely file a Form 3 reporting ownership of 4,687,000 shares of common stock. Ownership of these shares was reported on a Form 3 filed in February 2002. ITEM 11. EXECUTIVE COMPENSATION EMPLOYMENT ARRANGEMENTS Gary S. Moskovitz. Mr. Moskovitz is employed by us as our President and Chief Executive Officer pursuant to an employment agreement dated as of May 3, 2001. The agreement provides for an initial base salary of US$414,747 (CDN$630,000) per year, a sign on bonus of US$19,750 (CDN$30,000) and an option to acquire up to 1,500,000 shares of our common stock. This option will vest in full upon change of control of Lumenon. Mr. Moskovitz is also entitled to a potential annual performance bonus equal to 50% of his base salary. For the period of May 7, 2001 to May 6, 2002, this bonus consisted of three performance objectives: (a) US$25,510 (CDN$38,750) upon the execution of a revised licensing agreement with McGill University and Polyvalor regarding certain of our patents, the terms of which are satisfactory to the board of directors; (b) US$25,510 (CDN$38,750) upon execution of a revised agreement with our convertible noteholders, the terms of which are satisfactory to the board of directors; and (c) US$51,020 (CDN$77,500) upon the accomplishment of either (i) the execution of a financing agreement which provides a minimum of CDN$15,000,000 or US$10,000,000 in working capital for Lumenon, or (ii) customer acceptance of at least 1,000 products (chips or 31 packaged components). In August 2002, the board of directors granted Mr. Moskovitz an extension until December 31, 2002 to accomplish the objective set forth in clause (c) of his performance bonus and also determined that the equity line financing with Crossover Ventures, Inc. entered into in August 2002 would not satisfy the second criterion. For the period from May, 2002 to May, 2003, this bonus will consist of (a) US$103,687 (CDN$157,500) payable in cash and (b) an option to purchase US$103,687 (CDN$157,500) shares of our common stock, which are available to Mr. Moskovitz upon the Company achieving certain product availability and product sales criteria on or before May 31, 2003. The agreement also provided that Mr. Moskovitz was entitled to a bridge loan from the Company for a maximum amount of CDN$300,000 at a preferred rate of interest determined by the Royal Bank of Canada and that was repayable within 180 days of its extension. In November 2001, we extended a bridge loan to Mr. Moskovitz for CDN$200,000 which enabled Mr. Moskovitz to purchase a residence in Quebec. The bridge loan was guaranteed by a mortgage on the residence purchased by Mr. Moskovitz. In April 2002, the board of directors approved a 90 day extension for the repayment of the bridge loan. On July 31, 2002, Mr. Moskovitz repaid the bridge loan and all accrued interest and the mortgage against the residence was discharged. Throughout the employment period and for a period of twelve months thereafter, the agreement restricts Mr. Moskovitz's ability to engage in activities competitive with those of ours. In addition, throughout the employment period and for a period of eighteen months thereafter, Mr. Moskovitz has agreed that he will not solicit or accept business with respect to products competitive with ours from any of our customers, nor will he hire, take away, or cause to be hired or taken away persons employed by us within the twelve months preceding the date of termination of his employment. The agreement may be terminated by us (i) in the event of the death or permanent disability of Mr. Moskovitz, or (ii) if Mr. Moskovitz commits certain acts constituting cause, including a material breach of the agreement. We may terminate Mr. Moskovitz without cause upon 30 days notice to Mr. Moskovitz, provided that we pay him all accrued base salary, any earned but unpaid bonus amounts at the date of termination on a prorated basis and any accrued but unused vacation benefits. If we terminate Mr. Moskovitz without cause, we are required to pay Mr. Moskovitz an amount equal to 15 months base salary and to maintain Mr. Moskovitz's health and insurance benefits, subject to the approval of our group insurers, until the earlier of 15 months from termination or when Mr. Moskovitz obtains other employment. In addition, if Mr. Moskovitz is terminated without cause, Mr. Moskovitz's stock options shall continue to vest until 15 months after his termination whereupon Mr. Moskovitz shall have 90 days to exercise any vested options. If we terminate Mr. Moskovitz without cause prior to May 7, 2003, Mr. Moskovitz shall be entitled to a relocation reimbursement of up to US$69,783 (CDN$106,000). If (i) we assign Mr. Moskovitz duties inconsistent with his salary, bonus, compensation, benefits, office or support staff, (ii) we relocate Mr. Moskovitz outside the United States or Canada without his consent, (iii) we materially breach any of our obligations under the agreement, (iv) we fail to use our best efforts to renew Mr. Moskovitz's work permit, (v) we ask Mr. Moskovitz to perform an illegal act, (vi) we fail to provide that the employment agreement is expressly assumed by any successor to all or substantially all of our business or assets, (vii) Mr. Moskovitz resigns as a result of unlawful discrimination as evidenced by a final court order, or (viii) Mr. Moskovitz loses his position as a director of Lumenon, and we do not materially remedy the 32 situation within 30 days written notice from Mr. Moskovitz, Mr. Moskovitz shall have the right to terminate his employment with us within 60 days of the occurrence of the applicable event and shall be entitled to the same severance payments and other benefits to which he would have been entitled had we terminated him without cause. Within six months after a transaction in which any party or group obtains ownership of 50% or more of the voting power of our securities or upon a sale of all or 50% or more of our assets, Mr. Moskovitz shall have the right to terminate his employment and shall be entitled to the same severance payments and other benefits to which he would have been entitled had we terminated him without cause. Mr. Moskovitz may, for any reason, terminate the employment agreement upon one month prior written notice to us. Mark P. Andrews. Dr. Mark P. Andrews is employed by us as our Vice President and Chief Technical Officer pursuant to an employment agreement dated as of February 27, 2002. The agreement provides for an initial base annual salary of US$181,040 (CDN$275,000) and the right to participate in any bonus program adopted and introduced by us. Pursuant to this agreement, we also granted Dr. Andrews an option to acquire up to 100,000 shares of common stock, which vested immediately. In addition, we agreed to lease an automobile for Dr. Andrews' use and to reimburse Dr. Andrews for all expenses and costs incurred by him related to the operation of the automobile. Throughout the employment period and for a period of twelve months thereafter, the agreement restricts Dr. Andrews' ability to engage in activities competitive with our activities. Dr. Andrews has agreed that he will not hire or take away or cause to be hired or taken away any of our employees throughout his employment period and for a period of eighteen months thereafter and that he will not hire any employee who was employed by us during the twelve months preceding the date of Dr. Andrews' termination with us. In addition, Dr. Andrews has agreed that he will not, for any reason, directly or indirectly, solicit or accept business with respect to products competitive with ours from any of our customers, including any prior parties who had been our customers at any time during the twelve month period preceding the date of Dr. Andrews' termination with us. The agreement may be terminated by us (i) with cause, as determined in our discretion, by providing Dr. Andrews with his accrued base salary and any accrued but unused vacation benefits earned as of the termination date; and (ii) without cause, by providing Dr. Andrews with his accrued base salary, any earned but unpaid bonus amounts and any accrued but unused vacation benefits earned as of the termination date plus an additional fifteen months of base salary. Dr. Andrews may terminate the employment agreement upon one month prior written notice to us. SUMMARY COMPENSATION The following table sets forth information with respect to the compensation for the fiscal years ended June 30, 2000, June 30, 2001 and June 30, 2002 to Gary S. Moskovitz, our President and Chief Executive Officer and Mark P. Andrews, our Vice President and Chief Technical Officer. In accordance with the rules of the Securities and Exchange Commission, the compensation set forth in the table below does not include medical, group life or other benefits 33 which are available to all of our salaried employees, and perquisites and other personal benefits, securities or property which do not exceed the lesser of US$50,000 or 10% of the total annual salary and bonuses for each of the persons shown in the table.

------------------- (1) Mr. Moskovitz became our President and Chief Executive Officer in May 2001. OPTION GRANTS The following table contains information concerning stock option grants made in fiscal 2002 to each of the executive officers identified in the Summary Compensation Table above. Each stock option grant has a term of ten years. The per share exercise price of all options described below represents the fair market value of our common stock on the trading date immediately preceding the grant date and are converted into United States dollars using the noon buying rate on the trading date immediately preceding the grant date. Amounts described in the following table under the heading "Potential Realizable Value at Assumed Rates of Stock Price Appreciation for Option Term" represent hypothetical gains that could be achieved for the options if exercised at the end of the option term. These gains are based on assumed rates of stock appreciation of 5% and 10% compounded annually from the date the options were granted to their expiration date. Actual gains, if any, on stock option exercises will depend on the future performances of the common stock and the date on which the options are exercised. No gain to the optionees is possible without an appreciation in stock price, which will benefit all stockholders commensurately.

------------------- (1) The option was granted on February 27, 2002 and vested immediately. 34 AGGREGATED OPTION EXERCISES IN LAST FISCAL YEAR AND YEAR-END OPTION VALUES The following table sets forth information concerning options exercised during fiscal 2002 by each of the executive officers identified in the Summary Compensation Table above and the number and value of unexercised stock options held by each of those executive officers. Amounts described in the following table under the heading "Value of Unexercised In-the-Money Options at Year-End" are based on the aggregate fair market value of the underlying shares of common stock on June 30, 2002 (US$0.20 per share), less the aggregate option exercise price. Amounts described in the following table under the heading "Value Realized" represent the difference between the aggregate fair market value of the underlying shares of common stock on the date of exercise and the aggregate exercise price.

DIRECTOR COMPENSATION We reimburse directors for reasonable out-of-pocket expenses incurred in attending meetings of the board of directors and any meetings of its committees. We pay Mr. Marcotte US$16,458 (CDN$25,000) per year for his service as the chairman of our board of directors. This payment is made directly to Gem Len Inc., of which Mr. Marcotte is a director. Under the amended and restated 2001 director stock option plan, each of our non-employee directors is automatically granted an option to purchase 10,000 shares of our common stock on the date of each annual meeting of stock holders (other than a director who was initially elected to our board at any such annual meeting or, if previously elected, at any time after the prior year's annual meeting of stockholders), provided that he or she is serving as a non-employee director immediately following the date of such annual meeting. In addition, from time to time, in our discretion, we grant equity awards to our non-employee directors under our stock option incentive plan, amended and restated 2001 director stock option plan and amended and restated 2001 stock incentive plan. In the past, it has been our practice to grant an option to purchase 50,000 shares of our common stock to any future non-employee director upon his or her election to our board and to grant each non-employee member of a committee of the board of directors an option to purchase 6,250 shares of our common stock for each committee meeting attended, up to maximum of 25,000 per fiscal year per committee. COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION Mr. Allard and Mr. Roy served on our compensation committee throughout fiscal 2002. Mr. Brunet served on the compensation committee during fiscal 2002, until April 2002 when Mr. Wong joined the compensation committee. No executive officer of Lumenon served during the year ended June 30, 2002 as a director or member of the compensation committee (or other committee serving an equivalent function) of any other entity, whose executive officers served on our board of directors or compensation committee. In connection with the hiring of Gary S. Moskovitz as our President and Chief Executive Officer in May 2001, Mr. Moskovitz entered into an employment agreement with the Company pursuant to which he was entitled to a bridge loan from the Company for a maximum amount of CDN$300,000 at a preferred rate of interest determined by the Royal Bank of Canada and that was repayable within 180 days of its extension. In November 2001, we extended a bridge loan to Mr. Moskovitz for CDN$200,000 which enabled Mr. Moskovitz to purchase a residence in Quebec. The bridge loan was guaranteed by a mortgage on the residence purchased by Mr. Moskovitz. In April 2002, the board of directors approved a 90 day extension for the repayment of the bridge loan. On July 31, 2002, Mr. Moskovitz repaid the bridge loan and all accrued interest and the mortgage against the residence was discharged. COMPENSATION COMMITTEE REPORT ON EXECUTIVE COMPENSATION Lumenon's executive compensation program is administered by the compensation committee of Lumenon's board of directors, which is currently comprised of three non-employee outside directors. The compensation committee is responsible for determining the compensation for each of our executive officers. This report addresses our compensation policies for fiscal 2002 as they affected Lumenon's executive officers, including the executive officers named in the tables above. Lumenon's executive compensation program is designed to align executive compensation with our business objectives and individual performance, to underscore the importance of stockholder value creation and to enable Lumenon to attract, retain and reward executive officers who contribute, and are expected to contribute, to Lumenon's long-term success. In establishing executive compensation, the compensation committee is generally guided by the following principles: - the total compensation payable to executive officers should be competitive with the compensation paid by comparable companies for officers in comparable positions; 35 - the total compensation payable to executive officers should reflect general economic conditions and economic conditions particular to our industry; and - individual compensation should include components that reflect the performance of the individual, teamwork and the achievement of corporate objectives. The compensation of Lumenon's executive officers primarily consists of a combination of base salary and equity-based compensation. The compensation committee subjectively determines the base salary for all executives, by reviewing the salaries for competitive positions in Lumenon's industry, the historical compensation levels of the executives, the individual performance of the executives in the preceding year and salary levels required by any applicable employment agreements. In fixing the base salary of all executive officers in fiscal 2002, the compensation committee reviewed survey data provided to Lumenon by outside resources showing compensation data for companies with revenues comparable to those of Lumenon. The survey contained information obtained from a broad set of companies within Lumenon's industry. Awards of stock options under Lumenon's stock incentive plans are designed to more fully align the long-term interests of Lumenon's executives and its stockholders and to assist in the retention of executives. Under each of our stock incentive plans, the exercise price of stock options we award is based upon the market price of Lumenon's common stock on the trading date immediately preceding the date of grant. Therefore, stock options do not become valuable to the holder unless the trading price of Lumenon's common stock increases above the price on the trading date immediately preceding the date of grant. Guidelines used by the compensation committee in awarding stock options to Lumenon's executive officers include the following: - duties and responsibilities of the individual; - performance of the individual; - total number of outstanding compensatory stock options granted by Lumenon; and - the size of prior stock option awards to the individual. The compensation committee considered the survey data and the other criteria set forth above as a basis for its subjective assessment that the salaries, bonuses and stock option elements of compensation established by it for fiscal 2002, including the base salary of Mr. Moskovitz, were appropriate. In particular, Mr. Moskovitz's compensation was based primarily upon the following factors: - Mr. Moskovitz's scope of responsibility, prior employment experience, prior employment performance and salary history; and 36 - the value of Mr. Moskovitz's contribution to Lumenon's performance and the anticipated value of Mr. Moskovitz's contribution to Lumenon's future performance. In addition to a base salary and stock options, Mr. Moskovitz's compensation also includes a bonus component. Mr. Moskovitz is eligible to receive an annual bonus based upon the achievement of specific objectives established by the board of directors. Section 162(m) of the Internal Revenue Code generally disallows a tax deduction to public companies for certain compensation in excess of US$1 million paid to the company's chief executive officer and the four other most highly compensated executive officers. Certain compensation, including qualified performance-based compensation, will not be subject to the deduction limit if certain requirements are met. The compensation committee reviews the potential effect of Section 162(m) periodically and generally seeks to structure the long-term incentive compensation granted to its executive officers in a manner that is intended to avoid disallowance of deductions under Section 162(m). Nevertheless, there can be no assurance that compensation attributable to awards granted under our stock incentive plans will be treated as qualified performance-based compensation under Section 162(m). In addition, the compensation committee may in the future reserve the right to use its judgment to authorize compensation payments, including stock-based compensation, that may be in excess of the limit when the compensation committee believes such payments are appropriate and in the best interest of our stockholders, after taking into consideration changing business conditions and the performance of our employees. By the compensation committee of the Board of Directors of Lumenon Innovative Lightwave Technology, Inc., Pierre-Andre Roy, Chairman Pierre-Paul Allard Michael G. Wong (since April 24, 2002) COMPARATIVE STOCK PERFORMANCE The following graph compares the cumulative total stockholder return on our common stock with the cumulative return of (a) the Russell 2000 Index and (b) an industry index of communication equipment companies compiled by Media General Financial Services, comprised of companies that design, develop, manufacture and market equipment for the communication industry. The graph assumes the investment of $100 on March 2, 2000, the date on which our common stock was registered under Section 12 of the Securities Exchange Act of 1934, as amended, in our common stock, the Russell 2000 Index and the communication equipment index prepared by Media General Financial Services, and assumes dividends, if any, are reinvested. The measurement point is the last trading day for the fiscal year ending June 30, 2002. 37 [GRAPH]

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS The following table sets forth information concerning our stock incentive plans, as of June 30, 2002, including the number of securities issued pursuant to each of the plans, the weighted-average of the exercise price of the underlying securities and the number of securities available for future issuance under each plan. Each of the Stock Option Incentive Plan, the Amended and Restated 2001 Stock Incentive Plan and the Amended and Restated 2001 Director Stock Option Plan have been approved by our board of directors and our stockholders. Our Amended and Restated 2001 Non-Officer, Non-Director Employee Stock Incentive Plan, a description of which follows below, was approved by our board of directors. 38

------------------- (1) In addition to being available for future issuance upon exercise of options that may be granted after June 30, 2002, 3,581,250 shares under the Amended and Restated 2001 Stock Incentive Plan may instead be issued in the form of restricted stock. (2) Consists of the following equity compensation plans: the Stock Option Incentive Plan, the Amended and Restated 2001 Stock Incentive Plan and the Amended and Restated 2001 Director Stock Option Plan. (3) Consists of the Amended and Restated 2001 Non-Officer, Non-Director Employee Stock Incentive Plan. In August 2001 we adopted the Amended and Restated 2001 Non-Officer, Non-Director Employee Stock Incentive Plan. In conjunction with the Amended and Restated 2001 Stock Incentive Plan and Amended and Restated 2001 Director Stock Option Plan, this plan is intended to replace our Stock Option Incentive Plan. Up to 2,000,000 shares of our common stock (subject to adjustment in the event of stock splits and other events) may be issued pursuant to awards granted under this plan. Types of Awards The Amended and Restated 2001 Non-Officer, Non-Director Employee Stock Incentive Plan provides for the grant of non-statutory stock options. Employees who are granted awards pursuant to the plan receive the right to purchase a specified number of shares of our common stock at a specified option price and subject to such other terms and conditions as are specified in connection with the option grant. The exercise price of the options granted, which may be greater than, equal to or less than the fair market value of our common stock on the date of grant, is determined by the board of directors at the time of grant. Options may not be granted for a term in excess of ten years. The plan permits the following forms of payment of the exercise price of options: (i) payment by cash or certified or bank check, (ii) delivery to us of an irrevocable undertaking by a broker to deliver sufficient funds or (iii) delivery to us of irrevocable instructions to a broker to deliver sufficient funds. Eligibility to Receive Awards Full-time employees, other than those employees who are also officers or directors of Lumenon or its subsidiaries, are eligible to be granted awards under the plan. The maximum number of shares with respect to which awards may be granted to any participant during any year under the plan may not exceed 1,923,943 shares (equal to 5% of the number of shares of our 39 outstanding common stock on August 14, 2001, the date the plan was approved by our board of directors). As of June 30, 2002, approximately 92 persons were eligible to receive awards under the plan. As of June 30, 2002, options to purchase 1,297,500 shares of our common stock had been granted to our employees and pursuant to these option grants, 245,417 shares of our common stock had vested and 11,667 shares of our common stock had been exercised. Administration The plan is administered by our board of directors. Our board of directors has the authority to adopt, amend and repeal the administrative rules, guidelines and practices relating to the plan and to interpret the provisions of the plan. Pursuant to the terms of the plan, our board of directors may delegate authority under the plan to one or more committees or subcommittees of our board of directors. Accordingly, our board of directors has delegated to the compensation committee authority to administer certain aspects of the plan. In addition, our board of directors may at any time amend, suspend or terminate the plan. If any award expires or is terminated, surrendered, canceled or forfeited, the unused shares of common stock covered by such award will again be available for grant under the plan. No option may be granted under the plan after August 13, 2011. However, awards previously granted may extend beyond that date. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT The following table sets forth certain information as of September 15, 2002 with respect to the beneficial ownership of shares of our common stock by: - each person known to us to own beneficially more than 5% of our outstanding shares of common stock; - our directors; - our President and Chief Executive Officer and our one other executive officer who was serving as an executive officer on June 30, 2002; and - all of our directors and executive officers as a group. As of September 15, 2002, we had 41,145,197 shares of common stock outstanding The number of shares beneficially owned by each stockholder is determined under rules promulgated by the Securities and Exchange Commission. The information is not necessarily indicative of beneficial ownership for any other purpose. Under these rules, beneficial ownership includes any shares as to which the individual has sole or shared voting power or investment power and any shares as to which the individual has the right to acquire beneficial ownership within 60 days after September 15, 2002 through the exercise or conversion of any stock option, warrant, preferred stock or other right. The inclusion in the following table of those shares, however, does not constitute an admission that the named stockholder is a direct or indirect beneficial owner of those shares. Unless otherwise indicated, to our knowledge, based upon information produced by the persons and entities named in the table, each person or entity 40 named in the table has sole voting power and investment power, or shares voting and/or investment power with his spouse, with respect to all shares of capital stock listed as owned by that person or entity. The address of each of our executive officers and directors is c/o Lumenon Innovative Lightwave Technology, Inc., 8851 Trans-Canada Highway, St-Laurent, Quebec, Canada H4S 1Z6.

----------------- * Less than 1% (1) Consists of 4,687,500 shares held directly by Andrewma Holding Inc., as exercised by its sole stockholder, 3474445 Canada Inc. Mark P. Andrews is the sole stockholder of 3474445 Canada Inc. Dr. Andrews disclaims beneficial ownership of such shares. 41 (2) Consists of 4,687,500 shares beneficially held by 3474445 Canada Inc., as exercised by its sole stockholder, Mark P. Andrews. The shares are held directly by Andrewma Holding Inc. 3474445 Canada Inc. is the sole stockholder of Andrewma Holding Inc. Dr. Andrews disclaims beneficial ownership of such shares. (3) Consists solely of stock options exercisable within 60 days of September 15, 2002. (4) Consists of 4,687,500 shares held directly by Andrewma Holding Inc., as exercised by its sole stockholder, 3474445 Canada Inc., of which Mr. Andrews is the sole stockholder and 47,500 shares held by Dr. Andrew's spouse. Dr. Andrews disclaims beneficial ownership of such shares. Also consists of 300,000 shares of common stock issuable upon the exercise of stock options exercisable within 60 days of September 15, 2002. (5) Includes 210,000 shares of common stock issuable upon the exercise of stock options exercisable within 60 days of September 15, 2002. (6) Includes 14,000 shares of common stock held by Gem Len, Inc., of which Mr. Marcotte serves as a director, and 11,000 held by Mr. Marcotte's spouse. Mr. Marcotte disclaims beneficial ownership of such shares. Also includes 203,750 shares of common stock issuable upon the exercise of stock options exercisable within 60 days of September 15, 2002. (7) Includes 562,500 shares of common stock issuable upon exercise of stock options exercisable within 60 days of September 15, 2002. (8) Includes 1,702,500 shares of common stock issuable upon the exercise of stock options exercisable within 60 days of September 15, 2002. ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS In connection with the hiring of Gary S. Moskovitz as our President and Chief Executive Officer in May 2001, Mr. Moskovitz entered into an employment agreement with the Company pursuant to which he was entitled to a bridge loan from the Company for a maximum amount of CDN$300,000 at a preferred rate of interest determined by the Royal Bank of Canada and that was repayable within 180 days of its extension. In November 2001, we extended a bridge loan to Mr. Moskovitz for CDN$200,000 which enabled Mr. Moskovitz to purchase a residence in Quebec. The bridge loan was guaranteed by a mortgage on the residence purchased by Mr. Moskovitz. In April 2002, the board of directors approved a 90 day extension for the repayment of the bridge loan. On July 31, 2002, Mr. Moskovitz repaid the bridge loan and all accrued interest and the mortgage against the residence was discharged. ITEM 14. CONTROLS AND PROCEDURES Not Applicable. 42 PART IV ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES, AND REPORTS ON FORM 8-K (a) The following documents are filed as part of this report: (1) Financial Statements - Auditors' Report to the Shareholders. - Consolidated Balance Sheets for the years ended June 30, 2002 and June 30, 2001. - Consolidated Statements of Operations for the years ended June 30, 2002, June 30, 2001, June 30, 2000 and from inception to June 30, 2002. - Consolidated Statements of Cash Flows for the years ended June 30, 2002, June 30, 2001, June 30, 2000 and from inception to June 30, 2002. - Consolidated Statements of Stockholders' Equity for the years ended June 30, 2002, June 30, 2001, June 30, 2000 and from inception to June 30, 2002. - Notes to Consolidated Financial Statements. (2) Financial Statement Schedules None. (3) Exhibits The Exhibits filed as part of this Annual Report on Form 10-K are listed on the Index to Exhibits immediately preceding such Exhibits, which Index to Exhibits is incorporated herein by reference. Documents listed on such Index to Exhibits and identified by asterisks are being filed as exhibits herewith. Documents otherwise identified are not being filed herewith and, pursuant to Rule 12b-32 under the Securities Exchange Act of 1934, reference is made to such documents as previously filed as exhibits filed with the Securities and Exchange Commission. Lumenon's file number under the Securities Exchange Act of 1934 is 000-27977. (b) Current Reports on Form 8-K. (1) On May 21, 2002, the Company filed a Current Report on Form 8-K dated May 16, 2002, reporting under Item 5 (Other Events) that the Company had received a letter from The Nasdaq Stock Market, Inc. ("Nasdaq") indicating that Nasdaq had determined to delist the Company's common stock from The Nasdaq National Market because the Company's common stock did not meet the minimum $1.00 bid price per share requirement for continued inclusion on that market. 43 (2) On June 7, 2002, the Company filed a Current Report on Form 8-K dated June 6, 2002, reporting under Item 5 (Other Events) that Nasdaq had approved the Company's application to list its common stock on The Nasdaq SmallCap Market. 44 LUMENON INNOVATIVE LIGHTWAVE TECHNOLOGY, INC. (A DEVELOPMENT STAGE ENTERPRISE) Consolidated Financial Statements Years ended June 30, 2002, 2001 and 2000 and period from inception to June 30, 2002 AUDITORS' REPORT TO THE STOCKHOLDERS.................................... F-2 FINANCIAL STATEMENTS Consolidated Balance Sheets.......................................... F-3 Consolidated Statements of Operations................................ F-4 Consolidated Statements of Cash Flows................................ F-5 Consolidated Statements of Stockholders' Equity...................... F-6 Notes to Consolidated Financial Statements.............................. F-7

F-1 AUDITORS' REPORT TO THE STOCKHOLDERS We have audited the consolidated balance sheets of Lumenon Innovative Lightwave Technology, Inc. (the "Corporation") as at June 30, 2002 and June 30, 2001 and the consolidated statements of operations, cash flows and stockholders' equity for the years ended June 30, 2002, 2001 and 2000 and for the period from inception (March 2, 1998) to June 30, 2002. These financial statements are the responsibility of the Corporation's management. Our responsibility is to express an opinion on these financial statements based on our audits. With respect to the consolidated financial statements for the years ended June 30, 2002 and 2001, we conducted our audit in accordance with United States generally accepted auditing standards. With respect to the consolidated financial statements for the year ended June 30, 2000, we conducted our audit in accordance with Canadian generally accepted auditing standards. Those standards require that we plan and perform an audit to obtain reasonable assurance whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. In our opinion, these consolidated financial statements present fairly, in all material respects, the consolidated financial position of the Corporation as at June 30, 2002 and June 30, 2001 and the consolidated results of its operations and cash flows for the years ended June 30, 2002, 2001 and 2000 and for the period from inception (March 2, 1998) to June 30, 2002, in accordance with United States generally accepted accounting principles. The accompanying consolidated financial statements have been prepared assuming the Corporation will continue as a going concern. As discussed in note 1 to the consolidated financial statements, the Corporation has not yet established a source of revenue. This raises substantial doubt about its ability to continue as a going concern without raising additional capital. Management's plan in regard to these matters is also described in note 1. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. /s/ KPMG LLP Chartered Accountants Montreal, Canada August 9, 2002, except as to note 14 which is at August 14, 2002 F-2 LUMENON INNOVATIVE LIGHTWAVE TECHNOLOGY, INC. (A DEVELOPMENT STAGE ENTERPRISE) Consolidated Balance Sheets (In thousands of dollars)

See accompanying notes to consolidated financial statements. On behalf of the Board: Director ----------------------- Director ----------------------- F-3 LUMENON INNOVATIVE LIGHTWAVE TECHNOLOGY, INC. (A DEVELOPMENT STAGE ENTERPRISE) Consolidated Statements of Operations (In thousands of dollars, except per share amounts)

See accompanying notes to consolidated financial statements. F-4 LUMENON INNOVATIVE LIGHTWAVE TECHNOLOGY, INC. (A DEVELOPMENT STAGE ENTERPRISE) Consolidated Statements of Cash Flows (In thousands of dollars)

See accompanying notes to consolidated financial statements. F-5 LUMENON INNOVATIVE LIGHTWAVE TECHNOLOGY, INC. (A DEVELOPMENT STAGE ENTERPRISE) Consolidated Statements of Stockholders' Equity Years ended June 30, 2002, 2001 and 2000 and period from inception to June 30, 2002 (In thousands of dollars)

See accompanying notes to consolidated financial statements. F-6 LUMENON INNOVATIVE LIGHTWAVE TECHNOLOGY, INC. (A DEVELOPMENT STAGE ENTERPRISE) Notes to Consolidated Financial Statements Years ended June 30, 2002, 2001 and 2000 and period from inception to June 30, 2002 (In thousands of Canadian dollars, except per share amounts) 1. ORGANIZATION AND BUSINESS ACTIVITIES: Lumenon Innovative Lightwave Technology, Inc. ("Lumenon" or the "Corporation") was incorporated in the State of Delaware in February 1996 under the name of WWV Development Inc. as a shell company. In July 1998, under an acquisition plan, Lumenon acquired LILT Canada Inc. ("LILT"), a Canadian corporation, by issuing 12,200,000 common shares to the shareholders of LILT which resulted in the shareholders of LILT acquiring control of Lumenon. Accordingly, LILT has been determined the acquiring corporation and these consolidated financial statements present the results of operations and cash flows of LILT since its inception, March 2, 1998. Under the acquisition plan mentioned above, Lumenon issued 4,000,000 common shares to acquire Dequet Capital, Inc., a Nevada corporation. Dequet Capital, Inc.'s only asset was cash in the amount of $814 (US$540). This corporation was subsequently dissolved. The Corporation's principal business activity is to design, develop and build integrated optic devices in the form of compact hybrid glass circuits on silicon chips. Lumenon's current activities are performed only through LILT, in Canada. Lumenon was established to capitalize on innovations in compact optical circuit design and hybrid glass materials for integrated optics. In July 1999, Lumenon opened its pilot plant to support its ongoing research and development initiatives. In October 2000, the Corporation inaugurated its 53,000-square-foot facility. This facility serves as the Corporation's headquarters and, when operative, will be capable of high-volume manufacturing. In March 2001, in response to a perceived market downturn for optical components, the Corporation re-focused its strategy from one of providing only simple passive components to one of offering a mix of products and services ranging from optical chips to integrated photonic solutions. The Corporation is subject to a number of risks, including the overall economic environment in its field of activities, the successful development and marketing of its technology and the attraction and retention of key personnel. The Corporation's financial statements are prepared using the generally accepted accounting principles applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. However, the Corporation has no current source of revenue. Without the realization of additional capital, it would be unlikely for the Corporation to continue as a going concern. It is management's plan to seek additional capital in order to finalize the development of its products and to enter into the commercialization phase of such products. In connection therewith and as part of management's plan, the Corporation entered into a common stock purchase agreement in August 2002, as described in note 14. F-7 2. SIGNIFICANT ACCOUNTING POLICIES: These financial statements have been prepared by management in accordance with accounting principles generally accepted in the United States. The significant accounting principles are as follows: (a) Consolidated financial statements and basis of presentation: The consolidated financial statements include the accounts of Lumenon and the accounts of LILT. All intercompany transactions and balances have been eliminated. US dollar amounts presented on the consolidated balance sheets, consolidated statements of operations and cash flows are provided for the convenience of readers and are based on the noon buying rate in New York City for cable transfers in foreign currencies as certified for customs purposes by the Federal Reserve Bank of New York at June 30, 2002, which was $1.5190 Canadian dollar for each US dollar. The functional currency of the Corporation is the Canadian dollar. (b) Cash and cash equivalents: The Corporation considers all investments that are highly liquid with an original maturity of three months or less and readily convertible into cash to be cash equivalents. (c) Property and equipment: Equipment and leasehold improvements are recorded at cost. Depreciation and amortization are provided using the straight-line method and the following periods:

F-8 2. SIGNIFICANT ACCOUNTING POLICIES (CONTINUED): (d) Research and development costs: Research and development costs and the cost of intangibles that are purchased from others for use in research and development activities and that have no alternative future uses are expensed as incurred. Research tax credits on eligible research expenses incurred in Canada are accounted for as a reduction of research and development expenses. (e) Government assistance: Government assistance is recorded as a reduction of the expenses or the assets for which it was obtained. (f) Foreign exchange: The Canadian dollar is the functional currency of the Corporation. Foreign denominated monetary assets and liabilities are translated at the rate of exchange prevailing at the balance sheet date. Non-monetary assets and liabilities are translated at the rate of exchange prevailing at the date of the transaction. Revenues and expenses are translated at the monthly average exchange rate prevailing during the period. Foreign exchange gains and losses are included in the determination of net earnings. (g) Income taxes: The Corporation uses the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. This method also requires the recognition of future tax benefits such as net operating loss carryforwards, to the extent that realization of such benefits is more likely than not. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the statement of operations in the period that includes the enactment date. F-9 2. SIGNIFICANT ACCOUNTING POLICIES (CONTINUED): (h) Stock option plan: The Corporation applies the intrinsic value-based method of accounting prescribed by Accounting Principles Board ("APB") Opinion no. 25, Accounting for Stock Issued to Employees, and related interpretations for stock options granted to employees. As such, compensation expense would be recorded on the date of grant only if the then current market price of the underlying stock exceeded the exercise price. The Corporation applies FASB Statement 123, Accounting for Stock-Based Compensation ("SFAS 123") for stock options granted to non-employees. As such, compensation expense is recorded at the date of grant, based on the fair value as at that date using the Black-Scholes option-pricing model. (i) Impairment of long-lived assets and long-lived assets to be disposed of: The Corporation accounts for impairment of long-lived assets in accordance with the provisions of SFAS No. 121, Accounting for the Impairment of Long-Lived Assets and for Long-Lived Assets to Be Disposed of. This statement requires that long-lived assets be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell. (j) Net loss per share: Net loss per share is computed using the weighted average number of shares outstanding during the period. (k) Use of estimates: The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, namely government contributions and tax credits receivable and property and equipment as well as disclosure of commitments and contingent liabilities at the date of the financial statements and the reported amounts of expenses during the reporting periods. Actual results could differ from those estimates. F-10 2. SIGNIFICANT ACCOUNTING POLICIES (CONTINUED): (l) Recent accounting pronouncements: In August 2001, the FASB issued SFAS No. 143, "Accounting for Asset Retirement Obligations." SFAS No. 143 requires the Corporation to record the fair value of an asset retirement obligation as a liability in the period in which it incurs a legal obligation associated with the retirement of tangible long-lived assets. This statement is effective for the Corporation's fiscal year beginning July 1, 2002. The Corporation does not expect SFAS No. 143 to have a material impact on its financial statements. In October 2001, the FASB issued SFAS No. 144, "Accounting for the Impairment or Disposal of Long-Lived Assets." SFAS No. 144 provides accounting guidance for long-lived assets to be held and used, to be disposed of other than by sale, and to be disposed of by sale. This statement is effective for the Corporation's fiscal year beginning July 1, 2002. The Corporation does not expect SFAS No. 144 to have an initial material impact on its financial statements upon adoption. In June, 2002, the FASB issued SFAS No. 146 "Accounting for Costs Associated with Exit or Disposal Activities." SFAS No. 146 addresses financial accounting and reporting for costs associated with exit or disposal activities and nullifies EITF Issue No. 94-3, "Liability recognition for certain Employee Termination Benefits and other costs to Exit an Activity (including certain costs incurred in a restructuring)." This statement states that a commitment to an exit or disposal plan no longer will be a significant basis for recording a liability for those activities. The statement is effective for exit or disposal activities that are initiated after December 31, 2002. The Corporation does not expect to have an initial material impact on its financial statements upon adoption. 3. LOAN RECEIVABLE FROM AN OFFICER: The loan bears interest at a rate of 3.25% and was repaid in July 2002. F-11 4. PROPERTY AND EQUIPMENT:

During 2001, Lumenon acquired certain equipment anticipated to be used in production. Subsequently, the Corporation concluded it needed to further pursue the development of its products and, as a result, commencement of related production activity was delayed. Because Lumenon is a development stage enterprise, the recoverability of plant equipment and laboratory installation to be used in commercial production has been established at fair value. In connection therewith, write-offs of $1,481 and $2,513 on the equipment for which management believes there will be no future use due to technological changes, have been recorded during the year ended June 30, 2002 and 2001, respectively. Fair value is based on information obtained from suppliers and other companies operating in the same field of activity. 4. PROPERTY AND EQUIPMENT (CONTINUED): Property and equipment held under capital leases are as follows:

F-12 5. CONVERTIBLE NOTES: On July 25, 2000, the Corporation closed a financing involving the issuance of five-year convertible notes in the aggregate gross principal amount of $51,243 (US$35,000) bearing interest at the rate of 7.5% per annum. Interest was payable upon the earlier of the repayment or conversion of a note. Under the terms of the original agreement, the notes were convertible at any time by the holder into the Corporation's common stock at a conversion price based on the closing bid price of the common stock at the time of conversion with a floor of $11.17 (US$7) and a ceiling of $39.90 (US$25). In addition, the investors also received five-year common stock purchase warrants entitling them to acquire a total of 5,000,800 shares of the Corporation's common stock. This transaction was recorded under APB-14 ("Accounting for Convertible Debt and Debt Issued with Stock Purchase Warrants") and EITF 98-5 ("Accounting for Convertible Securities with Beneficial Conversion Features or Contingently Adjustable Conversion Ratios"). As a result, the convertible notes were discounted and are presented net of the debt discount, which is amortized over the term of the notes. Amortization is presented under financing charges in the consolidated statements of operations. In 2001, interest expense with respect to the beneficial conversion feature of convertible notes was included under financing charges as well. F-13 5. CONVERTIBLE NOTES (CONTINUED): On October 9, 2001, the Corporation and the investors agreed to amend the terms of the documents pertaining to the July 25, 2000 convertible notes financing. The convertible notes were amended and restated to provide for a fixed conversion price of US$1.44 for a common share, to eliminate certain restrictive covenants and to eliminate certain events of default pertaining to the Corporation. As security for the repayment of the amended and restated convertible notes, the Corporation granted the investors a security interest in all of the Corporation's present and future moveable property, rights and assets. This security interest is subordinated to any equipment lease financing or purchase money security interest of the Corporation. In addition, the common stock purchase warrants were cancelled and the securities purchase agreement and the registration rights agreement were amended to eliminate certain restrictive covenants. During 2001, $15,003 (net of debt discount) of the convertible notes including related interest was converted into 2,931,666 shares of common stock. During 2002, $4,280 (net of debt discount) of the convertible notes including related interest was converted into 2,485,503 shares of common stock. As a result of the above conversions, $13,722 (US$9,050) of the original gross principal amount remains outstanding. 6. OBLIGATIONS UNDER CAPITAL LEASES: Future minimum lease payments under capital leases are as follows:

F-14 6. OBLIGATIONS UNDER CAPITAL LEASES (CONTINUED): Interest on capital leases of $284 in 2002 and $199 in 2001 is included in interest expense. 7. SHARE CAPITAL:

(a) Issue of shares: As described in note 1, Lumenon acquired LILT in 1998 under a reorganization and acquisition plan by issuing 12,200,000 common shares to the shareholders of that corporation. At the date of acquisition, there were 255,000 outstanding common shares of Lumenon recorded at $0.372 (US$0.255). In addition, Lumenon issued 4,000,000 common shares to the shareholders of Dequet Capital, Inc. Assets of the latter consisted of cash in the amount of $814 (US$540). 1999 During the six-month period ended June 30, 1999, under a Stock Purchase Agreement, Molex Incorporated ("Molex") agreed to purchase from Lumenon 3,000,000 common shares at $0.74 (US$0.50) per share in two transactions. During the period, the Corporation issued 3,760,000 common shares (including 1,500,000 shares to Molex) for a cash consideration of $2,764 (US$1,880), along with warrants for the purchase of 3,926,667 common shares at a price of $1.32 (US$0.90) per share. F-15 7. SHARE CAPITAL (CONTINUED): (a) Issue of shares (continued): 2000 During the year ended June 30, 2000, the Corporation concluded the following share capital transactions: (i) 1,484,522 common shares were issued for a cash consideration of $7,099 (US$4,844), of which $147 (US$99) was received prior to June 30, 1999; (ii) promissory notes were converted into 400,000 common shares with a value of $299 (US$200); (iii) in connection with the issuance of common shares referred to in (i) and (ii), 1,912,211 warrants were issued at exercise prices ranging from $1.36 (US$0.90) to $45.42 (US$30.00) per share; (iv) under the Stock Purchase Agreement with Molex, an additional 1,500,000 common shares for a cash consideration of $1,093 (US$750) were issued; (v) 3,570,517 common shares were issued upon exercise of warrants and options for a cash consideration of $6,104 (US$4,171); (vi) 5,800,000 common shares were issued upon the exercise of a warrant and in connection with services received from Molex in the amount of $217,359 (US$147,003). The value of the shares issued has been recorded as Molex fulfilled its obligations pursuant to a Teaming Agreement. The transaction was accounted for by using the average market price of the shares of the Corporation during the periods that the services were rendered by Molex. 2001 During the year ended June 30, 2001, the Corporation issued 2,577,200 common shares upon exercise of warrants and options for a cash consideration of $6,037 (US$4,096) and 2,931,666 common shares as a result of the conversion of convertible notes (note 5). 2002 During the year ended June 30, 2002, the Corporation issued 19,967 common shares upon exercise of options for a cash consideration of $16 (US$11) and 2,485,503 common shares as a result of the conversion of convertible notes (note 5). F-16 7. SHARE CAPITAL (CONTINUED): (b) Stock option plan: In May 1999, the Corporation established a stock-option incentive plan for key employees, directors, officers and service-providers to purchase a maximum of 6,000,000 shares of common stock. In addition, the Corporation has established the following plans to supplement the May 1999 stock option incentive plan: - 2001 stock incentive plan (4,000,000 shares of common stock) - 2001 director stock option plan (600,000 shares of common stock) - 2001 non-director, non-officer employee stock incentive plan (2,000,000 shares of common shares) The common shares as per the above plans may be issued pursuant to awards granted under these plans. The terms, number of common shares covered by each option as well as the permitted frequency of the exercise of such options are determined by the Board of Directors. No optionee can hold options to purchase more than 5% of the number of shares issued and outstanding at the date the plans were adopted. The exercise price for each share covered by an option is established by the Board of Directors, except for the 2001 director stock option plan under which the exercise price shall be equal to the market value at the date of the grant. Options granted shall be exercised over a period not exceeding ten years. At June 30, 2002, 2,091,416 outstanding options are exercisable and 3,192,834 outstanding options vest over a period of one to five years. However, certain rights are provided under the terms of the plans in connection with reorganization or acquisition events, as defined in the plans. F-17 7. SHARE CAPITAL (CONTINUED): (b) Stock option plan (continued): (i) Changes in outstanding options for the period were as follows:

F-18 7. SHARE CAPITAL (CONTINUED): (b) Stock option plan (continued): (ii) The following table summarizes significant ranges of outstanding options as at June 30, 2002:

(iii) The following table summarizes the weighted average grant date fair value of options granted during 2002:

F-19 7. SHARE CAPITAL (CONTINUED): (b) Stock option plan (continued): (iv) Stock-based compensation: In 2001, the Corporation changed the exercise period for certain options previously granted. In addition, the exercise price of certain stock options was below the market price of the stock at the date of grant. Accordingly, compensation costs of $787 in 2002 and $4,936 in 2001 have been recognized for the above stock options granted to employees in the financial statements. Had the compensation cost for the Corporation's stock option plan been determined based on the fair value at the grant dates for awards under the plan consistent with the method of FASB Statement 123, Accounting for Stock-Based Compensation ("SFAS 123"), the Corporation's net loss would have been adjusted to the pro-forma amounts indicated below:

F-20 7. SHARE CAPITAL (CONTINUED): (b) Stock option plan (continued): (iv) Stock-based compensation (continued): The fair value of each option grant was estimated on the date of grant using the Black-Scholes option-pricing model with the following assumptions: risk-free interest of 5.5% to 5.8%, dividend yield of 0%, expected volatility varying from 200% to 390% and expected life of 5 to 7.5 years. The per share weighted average fair value of stock options granted during 2002, 2001 and 2000 was $0.82, $14.74 and $0.87, respectively. (c) Warrants: The following warrants are outstanding at June 30, 2002:

8. COMMITMENTS: (a) Under the terms of a license agreement, Lumenon has the rights to produce, sell, distribute and promote products derived from the know-how relating to integrated optical components for Dense Wavelength Division Multiplexing and Plastic Optical Fibre devices for telecommunications, data communications and sensor applications. Lumenon is committed to pay a royalty on gross sales up to a maximum amount of approximately $3,600 (US$2,400) until October 2017. The Corporation also entered into a non-exclusive license for patents with a third party in connection with array wave guides until the last patent expires. Lumenon is committed to pay a royalty on net sales at various rates which are based on the level of sales realized. F-21 8. COMMITMENTS (CONTINUED): (b) The Corporation leases premises under an operating lease agreement that expires in July 2012. This lease requires the Corporation to pay all executory costs such as maintenance and insurance. Rental payments under the terms of this lease are secured by a deposit of $750 (US$507), of which $75 (US$50) is refundable per year, beginning in fiscal 2002. In addition, the Corporation leases certain equipment under operating leases. An agreement with a lessor is secured by a deposit of $184. Minimum lease payments under operating lease agreements for premises and equipment for the next five years and thereafter are as follows: 2003 $ 919 2004 897 2005 888 2006 883 2007 877 Thereafter 4,376 ----------- $ 8,840 ===========

(c) The Corporation is committed to acquire equipment through capital leases in the amount of $97 (US$64) plus interest of $17. (d) The following schedule shows the composition of total rental expense for all operating leases: ~~2000 $ 78 2001 810 2002 875~~

F-22 8. COMMITMENTS (CONTINUED): (e) The Corporation entered into employment agreements in prior years with certain employees expiring at various dates in 2004 and 2005. Under the terms of these agreements, the Corporation is committed to pay salaries of approximately $704 in 2003, $693 in 2004 as well as $366 in 2005. In addition, certain agreements provide for indemnities if terminated under certain conditions. 9. INCOME TAXES: Details of the components of income taxes are as follows:

F-23 9. INCOME TAXES (CONTINUED): At June 30, 2002, Lumenon and its subsidiary, LILT, the Canadian Corporation, had accumulated scientific research and experimental development expenditures and other unclaimed deductions which are available to reduce future years' taxable income. Details of the available deductions are as follows:

Losses carried forward expiring in: - 2006 -- 488 532 - 2007 -- 5,015 5,015 - 2008 -- 9,278 9,278 - 2009 -- 8,923 8,923 - 2019 254 -- -- - 2020 387 -- -- - 2021 2,590 -- -- - 2022 1,823 -- --

In addition, research tax credits, not recorded in the accounts and available to reduce future Canadian Federal income taxes payable, are as follows:

F-24 9. INCOME TAXES (CONTINUED): The income tax effect of temporary differences that give rise to the net deferred tax assets, net of the valuation allowance, is presented below:

In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income and tax planning strategies. Since the Corporation is a development stage corporation and it has not yet generated taxable income, the generation of future taxable income is dependent on the successful commercialization of its products and technologies. F-25 10. SUPPLEMENTAL CASH FLOW DISCLOSURE: (a) Net change in operating assets and liabilities:

(b) Non-cash investing and financing activities: Acquisition of property and equipment through capital leases amounts to $685 (US$451) at June 30, 2002 (2001 - $2,581). Acquisition of property and equipment of $50 (US$33) is included in accounts payable at June 30, 2002 (2001 - $461). In addition, government contribution receivable of $1,250 deducted from property and equipment in 2001 was reversed in 2002 due to non compliance of confident conditions. 11. FINANCIAL INSTRUMENTS: (a) Foreign currency risk management: Certain options and warrants are exercisable in US dollars and payable in such currency. Convertible notes are also payable in US dollars. Ultimate proceeds upon exercise of options and warrants as well as repayment of convertible notes, if any, may vary due to fluctuations in the value of the Canadian dollar relative to the US dollar. F-26 11. FINANCIAL INSTRUMENTS (CONTINUED): (b) Credit risk: Financial instruments that potentially subject the Corporation to significant concentrations of credit risk consist principally of short-term investments and accounts receivable. The Corporation has investment policies that require that short-term investments be in commercial papers of recognized institutions evaluated as highly creditworthy. In the normal course of business, the Corporation evaluates the financial condition of the parties with which it contracts on a continuing basis and reviews the creditworthiness of all new parties. The Corporation determines an allowance for doubtful accounts to reflect specific risks. (c) Fair values: The following table presents the carrying amounts and estimated fair values of the Corporation's financial instruments at June 30, 2002 and 2001. The fair value of a financial instrument is the amount at which the instrument could be exchanged in a current transaction between willing parties. Fair value estimates are made as of a specific point in time using available information about the financial instrument. These estimates are subjective in nature and often cannot be determined with precision.

The carrying amounts of the above-mentioned assets and liabilities approximate their fair value because of the short maturity of these instruments. F-27 11. FINANCIAL INSTRUMENTS (CONTINUED): (c) Fair values (continued): In addition, the fair value of the convertible notes amounts to $11,772 (US$7,750). With respect to 2001, the fair value of the convertible notes and the related 5,800,000 warrants (see note 5) amounted to $15,140 and $3,028, respectively. The fair value of the convertible notes (and warrants issued along with the notes in 2001) was established by an independent expert who has utilized recognized financial models including volatility of stock and interest rates. 12. CONTINGENCIES: In connection with employee terminations that occurred during the past fiscal year, three employees filed lawsuits claiming various amounts with respect to damage and loss related to their forfeitures and the outcome, if any, is unpredictable at this time. The Corporation believes that the legal actions are without merit and intends to vigorously defend such lawsuits. 13. COMPARATIVE FIGURES: Certain of the 2001 comparative figures have been reclassified to conform with the basis of presentation adopted in the current year. 14. SUBSEQUENT EVENT: Under the terms of a common stock purchase agreement entered into on August 14, 2002, Lumenon has the option to receive a maximum of US$14,000,000 by issuing shares of its common stock in a series of periodic draw-downs of funds. The draw-downs are subject to certain limitations and the fulfillment of certain conditions, including a provision which limits the investor's holdings to 9.999% of the outstanding shares of Lumenon common stock at any given time and, the receipt of stockholder approval for draw-downs which will result in the issuance of common stock in excess of 19.9% of the common stock issued and outstanding as of the date of the agreement. These limitations and conditions will limit the amount which Lumenon may draw from time to time. The price of the shares of common stock to be issued to the investor will be based on a discount from 8% to 13% of the volume weighted average price of the common stock during the draw-down period as defined in the agreement. Lumenon has no obligation to draw down the full amount of the commitment. F-28 14. SUBSEQUENT EVENT (CONTINUED): In connection with this agreement, Lumenon issued a warrant to the investor to purchase 140,000 shares of Lumenon's common stock at an exercise price of $0.21 per share, within 30 days of the agreement. Lumenon has undertaken to issue to the investor an additional warrant to purchase 140,000 shares of Lumenon common stock at an exercise price of $0.21 per share. 15. QUARTERLY FINANCIAL DATA (UNAUDITED): The following table contains selected unaudited Statement of Operations information for each quarter of years ended June 30, 2002, 2001 and 2000. The Corporation believes that the following information reflects all normal recurring adjustments necessary for a fair presentation of the information for the periods presented. The operating results for any quarter are not necessarily indicative of results for any future period.

F-29 15. QUARTERLY FINANCIAL DATA (UNAUDITED) (CONTINUED):

F-30 SIGNATURES Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Annual Report on Form 10-K/A to be signed on its behalf by the undersigned, thereunto duly authorized. LUMENON INNOVATIVE LIGHTWAVE TECHNOLOGY, INC. October 28, 2002 By: /s/ Gary S. Moskovitz --------------------------------- Gary S. Moskovitz President and Chief Executive Officer CERTIFICATIONS I, GARY S. MOSKOVITZ, CERTIFY THAT: (1) I have reviewed this annual report on Form 10-K/A of Lumenon Innovative Lightwave Technology, Inc.; (2) Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report; and (3) Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report. Date: October 28, 2002 /s/ Gary S. Moskovitz --------------------------------- Gary S. Moskovitz President and Chief Executive Officer and Acting Chief Financial Officer (principal executive officer and principal financial officer) INDEX TO EXHIBITS

10.12(7) Security Agreement, dated as of October 30, 2001, between Lumenon Innovative Lightwave Technology, Inc., Capital Ventures International and Castle Creek Technology Partners LLC. 10.13(7) Deed of Hypothec, dated as of October 30, 2001, between Lumenon Innovative Lightwave Technology, Inc. and CIBC Mellon Trust Company. 10.14(7) Deed of Hypothec, dated as of October 30, 2001, between LILT Canada Inc. and CIBC Mellon Trust Company. #10.15(1) Stock Option Incentive Plan. #10.16(7) Amended and Restated 2001 Director Stock Option Plan. #10.17(7) Amended and Restated 2001 Non-Officer, Non-Director Employee Stock Incentive Plan. #10.18(7) Amended and Restated 2001 Stock Incentive Plan. +10.19(9) Joint Development and Marketing Agreement dated as of March 25, 2002 by and between Lumenon Innovative Lightwave Technology, Inc. and Poly-Scientific, a business unit of Northrop Grumman. 10.20(9) Letter Agreement dated March 15, 2002 by and between Lumenon Innovative Lightwave Technology, Inc. and Poly-Scientific, a business unit of Northrop Grumman. 21(1) Subsidiaries of the Company. 23* Consent of KPMG LLP.

---------- * Filed herewith. + Portions omitted pursuant to a request for confidential treatment. # Management contract or compensatory plan or arrangement filed as an exhibit to this form pursuant to Items 14(a) and 14(c) of Form 10-K. (1) Previously filed with the Securities and Exchange Commission as an Exhibit to the Registrant's Registration Statement on Form 10 filed February 23, 2000, as amended (File No. 00-27977), and incorporated herein by reference. (2) Previously filed with the Securities and Exchange Commission as an Exhibit to the Registrant's Annual Report on Form 10-K, as amended, (File No. 00-27977), and incorporated herein by reference. (3) Previously filed with the Securities and Exchange Commission as an Exhibit to the Registrant's Current Report on Form 8-K filed August 20, 2001 (File No. 000-27977) and incorporated herein by reference. (4) Previously filed with the Securities and Exchange Commission as an Exhibit to the Registrant's Registration Statement on Form S-8 filed October 11, 2001 (File No. 000-27977) and incorporated herein by reference. (5) Previously filed with the Securities and Exchange Commission as an Exhibit to the Registrant's Current Report on Form 8-K filed April 27, 2001 (File No. 000-27977) and incorporated herein by reference. (6) Previously filed with the Securities and Exchange Commission as an Exhibit to the Registrant's Annual Report on Form 10-K filed September 8, 2000 (File No. 000-27977), and incorporated herein by reference. (7) Previously filed with the Securities and Exchange Commission as an Exhibit to the Registrant's Quarterly Report on Form 10-Q filed February 14, 2002 (File No. 000-27977), and incorporated herein by reference. (8) Previously filed with the Securities and Exchange Commission as an Exhibit to the Registrant's Quarterly Report on Form 10-Q filed May 15, 2002 (File No. 000-27977), and incorporated herein by reference. (9) Previously filed with the Securities and Exchange Commission as an Exhibit to the Registrant's Annual Report on Form 10-K filed September 30, 2002 (File No. 000-27977), and incorporated herein by reference.

LUMENON INNOVATIVE LIGHTWAVE TECHNOLOGY INC 10-K/A